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Human papillomaviruses (HPVs) are small DNA tumor viruses identified by their
characteristic ability to replicate as a nuclear plasmid in mitotically active basal keratinocytes. A
key characteristic of the HPV life cycle is the establishment of a stable maintenance phase
wherein the virus replicates at low copy number, which likely occurs in cells expressing little to
no E1 and E2. It is thought that HPV16 replicates in a once-per-cell-cycle manner during this
portion of its life cycle and presumably interacts with host chromosome replication and
maintenance factors to facilitate this replication. The adaptive radiation of papillomaviruses in
response to changing host factors was well demonstrated in this work with an examination of
the evolution of the Papillomaviruses’ E2 proteins and cognate binding sites as the virus has
adapted to infect new body tissues. Additionally, the yeast model of HPV replication we utilize in
our laboratory showed a varying ability to replicate in S. cerevisiae, again demonstrating that
the replication environment plays a significant role in the long-term success of papillomaviruses.
To further investigate these cellular factors, we investigated the role telomeric
maintenance factors may play in these processes. We have performed ChIP assays that have
shown that components of the telomere maintenance complex (shelterin) can bind to at least
four sites in the HPV genome, each of which contain nine-base telomere-repeat sequences

(TTAGGGTTA). We have shown that mutating these sites has a detrimental effect on the virus’s
ability to replicate under certain conditions. The shelterin complex interacts with a number of
important chromosome replication and maintenance proteins with such diverse functions as
DNA replication, chromosome segregation, and DNA repair, making it an ideal target for
coercion by a DNA virus utilizing a stable low-copy replication strategy. Interaction between
Telomer Repeat Binding Factor 2 (TRF2) and Epstein Barr Virus Nuclear Antigen 1 (EBNA1)
protein (a structural and functional homologue of E2) is required for replication of plasmids
containing the Epstein Barr Virus latent origin of replication. Kaposi’s Sarcoma Herpesvirus
(KSHV) Latency Associated Nuclear Antigen (LANA) protein (another homologue of E2) also
interacts with TRF2. Results from our Far-Western and co-immunoprecipitation assays show
that E2 interacts with TRF2 and other shelterin components. In summary, these results suggest
that TRF2, TRF1, Rap1, Pot1, and Tin2, plus certain DNA repair proteins, may regulate the
maintenance phase of the HPV lifecycle. E2 appears to be capable of mediating these
interactions.
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Chapter 1

Literature Review

Papillomaviruses
Papillomaviruses (PV) are small (55 nm diameter) non-enveloped viruses of
icosahedral capsid symmetry that house a single molecule of circular supercoiled double
stranded DNA (339). PVs have coevolved extensively with their mammalian hosts, such
that there have been human papillomaviruses (HPVs) essentially since the evolutionary
emergence of humans (31). This family of viruses infects body surface tissues such as
the skin or mucosal surfaces, which include the mouth, airways, and anogenital tissues
of vertebrate animals (75). According to the International Committee on Taxonomy of
Viruses, the family papillomaviridae has 16 assigned genera (alphapapillomavirus
through pipapillomavirus) and one unassigned genus (81). There are over 100 strains of
HPV identified at present (141) as well as numerous papillomaviruses that infect
mammals, birds, and reptiles. Papillomavirus strains are further classified by differences
in the major capsid protein sequence L1. New papillomavirus types are recognized if the
L1 gene has 10% difference in DNA sequence as compared to the closest known PV
type, a 2-10% difference constitutes a subtype and < 2% difference defines a variant
(82, 339). Alphapapillomaviruses are further classified into high and low risk categories
by their potential to cause cervical cancer (57, 220, 313).
Mucosal HPV types are the causative agents of cervical cancer as well as some
vaginal, anal, and penile cancers (37, 57, 220), typically as a result of genomic
integration and resultant overexpression of the viral E6 and E7 oncogenes(306). This
was initially described in 1982 with detection of HPV sequences in human tumors (128,
131, 332). High risk HPV DNA is found in greater than 95% of cervical cancers, making
it clear that this virus is the causative agent of this disease (221, 307). Of these, HPVs
16 and 18 are the most common causes, with HPV16 being present in over 50%, and

HPV18 10-12% of cervical cancers worldwide (36). HPV18 has been found in certain
geographic regions to be more prevalent than HPV16 (224). Additionally, emerging
research has implicated HPVs in some head and neck, anogenital, upper respiratory,
and even some non-melanoma skin cancers (68, 126, 152, 344).

Life Cycle of Papillomaviruses
The life cycle of papillomavirus is closely associated with the differentiation
profile of host keratinocytes. During the course of epithelial cell differentiation, the virus
shifts through three replication phases in response to keratinization: establishment,
wherein early viral replication occurs; maintenance, where the viral genome is stably
maintained episomally by replicating through a theta intermediate; and amplification,
where viral replication shifts to a rolling-circle mode and the copy number increases in
preparation for encapsidation (112). The virus typically enters the host through wounding
of the external epidermis, wherein the virus travels to the mitotically active basal
keratinocytes to establish infection. HPV binds to a number of sub-receptors before
eventually adhering to the candidate receptor α6 integrin and enters through clathrinmediated endocytosis (39, 75, 104, 143, 203, 277). Upon nuclear entry, the viral DNA is
transferred to the nucleus and promptly targeted to PML bodies, which enhances
transcription and are important for successful viral replication (74).
Upon establishing infection in the host, the virus shifts into the maintenance
phase of the life cycle. Gene expression of most of the open reading frames besides the
viral oncogenes E6 and E7 is repressed, and the virus is maintained at a copy number of
less than 20 per cell (105). Studies have demonstrated that the viral replication proteins
(E1 and E2) are required for establishment of viral infection, but may be dispensable
during the maintenance phase (159, 245). During this phase, the virus replicates in a

once-per-cell-cycle fashion which is reliant on a number of host factors for stability (114).
The virus can thus be maintained indefinitely in the basal layers of the epithelium.
As the cells of the basal layer divide, one cell remains attached to the basal layer
while the other migrates up through the squamous epithelia and begins to progress
through the keratinization and differentiation processes, which drives the HPVs into the
vegetative phase of their life-cycle. This phase is characterized by activation of the
keratin dependant promoter activity, increased expression of the viral proliferative genes,
and a shift from a once-per-mitosis bidirectional theta replication model of viral genome
replication to a rolling-circle mechanism along with an increase in expression of the L1
and L2 capsid genes (72, 114).

The HPV Genome
HPV has a small 8kb genome that consists of a long control region (LCR), early
gene region and a late gene region. The LCR is ~850 bp long and comprises 10% of
the viral genome. The LCR contains the origin of replication (ori) and multiple
transcription binding sites, thus controlling the expression of viral genes (141, 339). The
early gene region comprises 50% of the viral genome and encodes 6 open reading
frames (ORFs). The expression of genes in this and the late region is regulated by
alternative splicing due to the compact genome of the virus. The late gene region is the
last 40% of the viral genome and is downstream of the early region (339). Early genes
are expressed in undifferentiated or newly differentiated keratinocytes and late region
genes are expressed in keratinocytes undergoing terminal differentiation (202, 339).The
early genes (E1, E2, E6 and E7) are primarily responsible for replication, genome
maintenance, and the promotion of cell growth.

The viral E5 protein plays an important role in stimulating cellular proliferation.
The protein activates ligand independent activation of the growth factor receptor, downregulates Major Histocompatibility Complex I (MHCI), and deregulates the Golgi body
(11, 94, 334). E6 and E7 are bona fide oncogenes (192, 261). E7 binds to and
deactivates the Retinoblastoma (RB) cell-cycle regulation protein as well as other
members of the RB family of proteins in order to release E2F and progress the cell
cycle. E6 binds to and, with the action of an E3-Ubiquitin Ligase E6 Associated Protein
(E6AP), degrades p53 to down-regulate apoptosis. These genes combine to force the
cell into an S/G2-like state to promote cell-cycle progression, down-regulate terminal
differentiation processes, and promote viral genome replication.
The E4 protein is usually expressed as a spliced mRNA as part of the E1
transcript and is typically expressed in highly-differentiated cells. Its function is to sustain
the S-phase like state induced by other viral factors. E4 weakens virus laden cornified
envelopes and keratin filaments and alters the host cytoskeletal structure as a means of
promoting viral egress (44, 73, 98).
The L1 and L2 ORFs encode the major and minor capsid proteins, and are
expressed in the late-stages of the viral lifecycle (62, 243). L1 is the major capsid protein
and spontaneously organizes itself into pentameric structures that make up the majority
of the viral icosahedral capsid (109, 161, 341). L2 is the minor capsid protein and plays a
role in protein packaging, transporting DNA to the nucleus after viral entry, and
recruitment of E2 to viral replication foci (74, 76, 335).

E2
The E2 protein serves multiple functions, with its primary role being that of a
transcriptional regulator. It is a 350 to 500 amino acid protein expressed from a spliced
mRNA transcribed from different promoters. E2 also negatively regulates the expression

of the E6 and E7 oncoproteins(184). E2 polypeptides contain three probable domains: a
DNA binding domain (DBD) located at the C-terminus, an N-terminus transactivation
domain, and an internal “hinge” domain. Both the C-terminal and N-terminal domains are
relatively well conserved within the PVs (254). E2 binds as a dimer to DNA-binding sites
through action mediated by the DBD (202). The E2 DBD forms a dimeric β-barrel, with
each strand contributing a half-barrel. The dimer interface has a hydrophobic core and
uses extensive hydrogen bonding between subunits to maintain tight binding. This βbarrel core contains elaborately packed side chains that contribute to the stability of the
dimer. There is a poorly conserved loop connecting β-strands 2 and 3. This loop varies
from 6-10 residues. The tertiary structure of characterized E2 DBDs is similar, but there
appears to be variation in the orientations of the two subunits (141).
The transcriptional repression activity occurs as a result of E2 binding sites
overlapping TATA boxes or Sp1 sites and requires a functional transactivation domain
(30, 298). Conversely, E2 has transcriptional activation functions by inserting E2 binding
sites (E2BSs) upstream of thymidine kinase promoters in a Chloramphenicol Acetyl
Transferase (CAT) assay (52). Much of E2s ability to affect transcription comes from its
interaction with the Bromodomain 4 protein (Brd4), an essential cellular protein that
binds to acetylated lysines of Histone H3 and H4 (91) and stimulates RNA polymerase II
transcription (330, 331). E2 redistributes Brd4 into punctate dots scattered along the
chromosome (208) and increases Brd4’s affinity for binding to interphase chromatin
(208). Presumably, this is an effect of E2 utilizing Brd4 as a transcription factor (206).
There is evidence to suggest that the activation domain mediated oligomerization could
influence interaction between E2 molecules bound at distant E2-binding sites forming
DNA loops and other DNA structures (8, 141).
Expression levels of E2 in infected cells are a matter of some debate. High levels
of E2 expression in mammalian cells leads to activation of caspase-8 dependant

apoptosis (90, 118). While this seems counterintuitive, it is believed this interaction is
related to an observed role played by caspase-8 in differentiation of keratinocytes (118).
As such, only one cell line has been found which stably expressed E2 with episomal
HPV DNA (282) and it has never been observed in raft culture experiments utilizing
HPV16 and 18 (28). Observations of HPV infected cervical biopsies have determined
that E2 expression is primarily isolated to the more differentiated layers of low-grade
Cervical Intraepithelial Neoplasia (CIN) lesions but not in proliferating cells (28). High
levels of E2 expression thus appears to be restricted to differentiated cells in the
epithelium with high levels of keratin expression, but not in rapidly dividing cells (320).
One of E2’s most important functions is to tether the viral genome to replicating
chromosomes during mitosis to ensure proper segregation of viral plasmids to daughter
cells (201). Initially, this was theorized to be the result of an interaction with the
Bromodomain4 protein (BRD4), which is required for plasmid segregation and
transcriptional control in Bovine Papillomavirus 1. However, further studies
demonstrated that, while all papillomavirus E2 proteins studied thus far utilize Brd4 for
transcriptional purposes, it is dispensable for the plasmid maintenance in HPVs (206).
The maintenance function of E2 thus remains somewhat cryptic. Although binding of E2
to mitotic chromosomes is consistently observed, the binding location is not conserved
amongst PV types (231). Some studies have demonstrated that the beta-papillomavirus
HPV8 E2 protein has a binding preference for the rDNA gene region of acrocentric
chromosomes (231, 246) which contains a number of binding sites for E2 and, due to its
unique chromatin structure, can allow E2 to remain transcriptionally active (67, 119,
164). By contrast, the BPV1 E2 protein is observed during this phase as discreet
speckles associated with the papillomavirus genome scattered along the chromosome
(274). Alpha-papillomaviruses had a similar binding localization to HPV8, but while other
PVs are observed associated with the chromosome throughout mitosis, alpha-

papillomavirus genomes are only observed attached during prophase and telophase (97,
120, 231). This association is observed in other DNA viruses with long-term replication
strategies, as Epstein Barr Virus (EBV) Nuclear Antigen 1 (EBNA1) protein binds to a
pre-mRNA processing protein and localizes to the nucleolus during interphase ((50, 269)
and Kaposi’s Sarcoma Herpesvirus (KSHV) Latency Associated Nuclear Antigen (LANA)
binds to pericentromeric and telomeric regions of DNA similarly to E2 (231).
The consensus sequence 5’-ACCgNNNNcGGT-3’ is recognized by E2, with the
position 4 and 9 residues allowing some variability. A number of studies have been
performed to examine the binding of E2 protein to its cognate binding site (33, 83, 111,
141, 144, 249, 257, 293). The 4-nucleotide spacer sequence varies by HPV type, and
has been identified as being critical for determining E2 binding affinity through indirect
readout as well as playing a potential role in gene regulation, despite having no
predicted nucleotide-amino acid contacts from crystal structure (33, 83, 141, 144, 328).
E2 binds DNA as a homodimer with each monomer supplying an alpha helix to contact
two successive major grooves of the target site (83, 141)
Four typical E2 binding sites are conserved in the upstream regulatory region
(URR) of most papillomaviruses, numbered according to their distance from the early
promoter (202). Each site is differentially regulated and demonstrates variable binding
affinity for the E2 protein, resulting in varying replication and transcriptional effects
during the viral life cycle (63, 191) presumably as a result of differences in E2 binding
affinity (141) due to sequence variation as well as methylation of the E2 binding site
(257, 293). These binding sites are typically well conserved across all papillomaviruses.
However, in some cases variation in the number and location of some E2 binding sites
does exist, including a predicted fifth binding site within the URR of betapapillomaviruses
(103) and some alphapapillomaviruses (257) as well as up to 17 sequences with ability
to bind E2 from the URR of bovine papillomavirus 1 (22, 71, 170, 249, 273).

HPV Replication
Papillomavirus DNA replication requires primarily cellular factors, recruiting
polymerase alpha along with other elements of the cellular replication machinery (240).
The accepted model relies on the viral proteins E1 and E2 for genomic amplification (95,
250, 301). The viral origin of replication contains a minimum of one E1 and E2 protein
binding site (301). The E1 protein functions as an ATP dependent helicase and recruits
DNA polymerase alpha to act as an elongation factor (117, 217, 242). It is regulated by
extensive post-translational modification (172). E1 unwinds the viral genome through its
ATP-dependant helicase activity.
E1 is loaded onto the origin by the E2 protein, which is localized to the HPV
replication foci by the L2 protein (76). The two early proteins bind as dimers
cooperatively through an interaction between the N-terminus of E2 and the helicase
domain of E1 (259, 265). After loading E1, E2 dissociates from the viral genome while
E1 forms into a hexameric helicase ring, similar to that formed by the minichromosome
maintenance proteins (258, 262, 264, 296). At this point, E1 recruits Replication Protein
A (RPA), topoisomerase I, polymerase α primase, Proliferating Cell Nuclear Antigen
(PCNA), Replication factor C, and DNA Polymerase δ. (58, 61, 137, 166, 185, 197, 210,
219). E2 recruits a number of factors important for viral replication including
Transcription Factor II β, Transcription Factor IIδ, Activation Domain Modulation Factor-1
(AMF-1), Breast Cancer Associated protein 1 (BRCA1), Poly [ADP Ribose] Polymerase
1 (PARP1), Transcription initiation factor TFIID subunit 1 (TAF1), Topoisomerase I
(TopoI), DNA topoisomerase 2-binding protein 1 (TopBPI), and chromatin remodeling
P300/CBP-associated factor (p/CAF), transcriptional co-activators p300/CBP, Brahma
(BRM), hSNF5 and Nucleosome Assembly Protein (NAP-1), as well as Bromodomain-

Containing Protein 4 (BRD4) (reviewed in (27)). Once replication is completed, it is
suggested that an interaction between E2 and ChLR1, a DNA helicase involved in sister
chromatid cohesion, plays an important role in ensuring post-replication segregation of
viral genomes (239).
Previous research has indicated that papillomavirus genomes can be replicated
and maintained stably in the absence of E1 and E2 (7, 158, 336). Silencing mutations of
the individual HPV open reading frames have shown that none of the individual ORFs
are strictly required for successful genomic replication and maintenance in tissue culture
(7). Since it has been demonstrated that replication of papillomavirus genomes occurs
in the absence of viral proteins in yeast as well, it is apparent that conserved cellular
factors must play a role in replacing E1 function. For instance, the E1 protein forms
hexamers which function in a similar manner to cellular helicases such as Werner’s
(WRN) and Bloom’s (BLM) Syndrome Helicases, members of the RecQ family, and the
minichromosome maintenance proteins (MCM) (102, 117, 216, 242). It is conceivable,
then, that host factors could be adapted to perform similar replication functions in place
of viral proteins like E1, suggesting that an E1-independent mode of replication could be
relevant during the maintenance phase of the HPV lifecycle.

HPVs Replication in Yeast
Having initially established that HPV genomes can replicate in Saccaromyces
cerevisiae(7, 158), the HPV/yeast system has proven easy to manipulate to study many
aspects of the HPV lifecycle, including transcription, replication and production of viruslike-particles (VLPs). HPVs 6b, 11, 16, 18, and 31 can replicate in short-term assays
when transformed into competent yeast (5-7, 158, 336, 337). Furthermore, the Frazier
laboratory has reported that BPV1 replicates robustly in yeast (336, 337). Recently the

Khan laboratory has reported that HPV1 can replicate in yeast, but requires a
centromere to be maintained stably (51). Kim et. al. mapped both ARS and CEN
replication functions in S. cerevisiae to the late region of HPV16 (158). The great degree
of homology between the genomic replication mechanisms of yeast and higher
organisms creates the possibility that similar mechanisms could be involved in
papillomavirus replication in higher eukaryotes, especially during the maintenance phase
when replication factor transcription is minimal.

Structure of Telomeres and their Regulation:
Telomeric repeats, telomerase and T and D loops
Telomeres are essential structures that cap and protect ends of linear
chromosomes, hiding them from DNA damage sensing mechanisms and repair
machinery (77) and solving the problem of sequence loss from the ends of
chromosomes as a result of DNA replication through regulation of the telomerase
enzyme (reviewed in (60)). The last 50-500 bases of the telomere consist of a single
stranded G-rich overhang (77) sequestered into a T-loop lariat structure (79, 135), the
end of which is inserted into a complementary C-rich region, resulting in displacement of
the G to form a displacement or D-loop.
These protective functions are mediated by telomere associated protein activities
as well as formation of T-loops by these proteins (78, 79). Telomeric DNA consists of
tandem repeats of (TTAGGG)n synthesized by telomerase (60) an enzyme consisting of
the telomerase reverse transcriptase and terc, the RNA template from which the repeats
are synthesized (60). Telomerase is a reverse transcriptase similar to that utilized by
retrotransposons, which are their potential evolutionary ancestor (101). Telomerase is
conserved between vertebrates, invertebrates, plants, fungi and many unicellular

organisms (reviewed in (186). Dipterans, including Drosophila melanogaster, do not use
telomerase to maintain chromosome ends, relying instead on retrotransposition (32).
Certain immortalized human cell lines utilize alternate lengthening of telomeres (ALT) to
replicate telomeres in a telomerase independent manner (187) utilizing telomeretelomere recombination and t-loop-mediated extension.

Telomere-related factors and their functions
The telomere is maintained through the action of a number of proteins combined
together into a protein complex called shelterin. The shelterin/telosome complex
functions primarily by bringing the three telomeric DNA binding factors (TRF1, TRF2 and
Pot1) into the same large complex (78, 181, 237) along with Ras related protein 1
(RAP1) (173), and TRF1-TRF1 Interacting Protein (TIN2) (77). Studies suggest that the
shelterin complex binds preferentially to ds/ss-DNA junctions with a Pot1 binding site
and at least one Myb-domain (the DNA binding site for TRF proteins) (54). The shelterin
complex binds along the length of the telomere repeats and, as the telomere length
increases, negatively regulates the activation of the telomerase holoenzyme and, in
doing so, regulates the length of telomeres (106) (266). Thus, the shelterin complex
functions as a sort of telomerase-length thermostat, down-regulating the activity of the
telomerase enzyme as the telomere increases in length, allowing more shelterin to bind.
TRF1 and 2 (telomeric repeat factors 1 and 2) bind duplex telomeric DNA (43),
and are almost entirely associated with cellular chromatin (288). TRF1 and 2 share a
common architecture defined by two conserved regions: a TRFH domain that mediates
homodimerization and a carboxy-terminal DNA binding domain of the SANT/Myb family
(43). TRF1 forms long filaments of protein bound along the length of the telomere and
negatively regulate telomerase activity (133). TRF2 promotes development of T-loop

structures (134, 283), potentially as a result of positive supercoiling (4). TRF2 also
serves to stabilize T-loops (116) through their N-terminal domain’s ability to bind ss-DNA
in a number of secondary structures. TRF2 also recruits the MRE11 complex, which
functions for recombination and repair, as well as WRN and Blm helicases, more DNA
repair factors (236), that could facilitate the unwinding step that is involved in t-loop
formation. Loss of TRF2 leads to rapid reduction in telomere length, aberrant telomere
structural formations, and activation of p53 mediated apoptosis in cells due to the
proteins ability to interact with ATM (302, 309). A conditionally activated siRNA against
TRF1 and 2 in mouse cells resulted in activation of the non-homologous end joining
(NHEJ) system to aberrantly link the chromosomes of cells together into long chains
(266).
Pot1 (protection of telomere 1) is the human homologue of the G-overhang DNA
binding proteins present at the end of all telomeres, and is a structural homologue of
TEBP from various protist species and CDC13 from fusion yeasts. These proteins
feature a characteristic oligonucleotide-oligosaccharide binding fold within their DNA
binding surfaces that provides high sequence specificity for a minimum of two singlestranded telomeric DNA repeats typically found within 3’-overhang and in D loops (23,
171, 183, 214, 294, 321). Pot1 is localized on the T-loop of the telomere through
interphase and only dissociates when DNA replication is occurring, but can also be
found bound along duplex regions of T2AG3 repeats away from the single-stranded
loop, likely through an interaction with the TRF1/Tankyrase/Tin2 complex (310). The
protein has a number of phenotypic effects on the telomeres, including being
demonstrated to be both a positive and negative regulator of telomerase (9, 59, 183).
Loss of Pot1 due to siRNA, deletion, or expression of a TRF2 dominant negative mutant
to strip shelterin from the telomere leads to loss of telomere length, chromosomal
abnormality, and eventual induction of senescence and apoptosis (24, 322). One

explanation of the dual functions with regards to telomerase may come from the
protein’s association with TPP1, which heterodimerizes with Pot1 and regulates
recruitment of Pot1 to telomerase (160, 180, 227) and acts synergistically to recruit
telomerase (308, 319). S ceverisiae utilize Cdc13, a similar ssDNA binding protein, to
protect telomeres against exonucleolytic attack and prevents activation of DNA-damage
checkpoint by chromosome ends, in place of TRF2 (189)
Additionally, these proteins transition through a number of sub-complexes that do
not contain TRF1 or TRF2/RAP1 (47, 48, 145, 181, 237, 288, 327). TRF2 exists in two
separate pools of protein on the telomere, one with greater stability than the other (199).
Isolated chromatin has been found to contain vast molar excesses of TRF2, TIN2, and
RAP1 compared to other shelterin components, implying that they may form a separate
complex (288). One of these potentially is a complex dubbed “T2” by Choi et. Al. in in
vitro experiments containing TRF2, Pot1, TIN2, TPP1, and RAP1 (54) which seems to
be responsible for binding to the ends of telomeres and managing the T and D loops.

Replication Through Telomeres
Replication of telomeric DNA during regular cellular mitosis presents a number of
challenges for cells. DNA replication typically initiates from origins located in the subtelomeric region (311). Telomeric DNA replicates throughout S phase while subtelomeric
DNA only replicates at the end of the phase, which suggests that telomeres may have
their own separate origin of replication (151, 229, 290, 317). The first problem comes
from typical cellular replication of the telomere, known as the end replication problem. All
cells’ DNA-replication machinery utilizes short RNA primers to initiate DNA replication. In
the case of the telomeres, removal of the final primer from the 3’ end of the linear
chromosome leaves a short, unreplicated segment which cannot be filled in. Over time,

this would lead to gradually increasing loss of telomere sequence and eventually loss of
coding DNA [reviewed in (132)]. The cell corrects for this by utilizing the telomerase
holoenzyme for the leading strand, paired with synthesis of the lagging strand by small
RNA primers utilizing polymerase primase (70, 338). In budding yeast, this occurs at the
same time as G-strand synthesis and seems to regulate telomerase activity (93, 226,
312), whereas in humans the two activities are separate (338) and lagging strand
synthesis is controlled by activation of cyclin dependant kinase 1 (CDK1) (70). In
budding yeast, it has been shown that DNA polymerase α primase is essential for
telomerase extension of telomere ends (93) to compensate for the G-overhang. Similar
results have been observed in fission yeast (69) and mouse cells (222). The last
segment of the telomere thus consists of one of these primers, which is then removed by
nucleases, leaving a short single stranded G-overhang, which then form the T-loop.
The second problem has to do with the actual progress of replication forks
through telomeres themselves. Progress of the replication loop must deal with a number
of uniquely challenging secondary structures when processing through the telomeres,
including G-quadruplexes, heterochromatinized DNA, and the t-loop itself. Gquadruplexes are stable intra-molecular structures which occur through the formation of
Hoogsteen base-pairs between four guanine residues (142). Organisms utilize the Blm
and Wrn helicases to further the replication fork migration, as well as replication protein
A (RPA) and Pot1 (256, 333). Most of the telomere consists of regions of the genome
which are bound by nucleosome arrays(297) with histones that have been specifically
modified to consist of highly repressed structures known as heterochromatin (121, 129),
which negatively regulates telomere length (29). The mechanisms by which this is
regulated are not well understood, but are predicted to involve complex levels of
epigenetic control. Telomeric DNA has a tendency to cause replication forks to slip
backwards and generate complicated replication structures like Holliday Junctions or

chickenfoot structures which need to be resolved for successful DNA replication (115).
Additionally, the t-loop itself is difficult for cells to resolve and is a site at which
supercoiling stress accumulates during the course of DNA replication. Unwinding of this
structure is essential to allow efficient DNA replication. TRF1 and fission yeast
homologue protein Taz1 promotes efficient replication of telomeric DNA by preventing
fork stalling (211, 268), but unfortunately it is not sufficient to prevent all potential
replication difficulties. All of these potential replication fork obstacles can result in
accumulation of stalled replication forks within the telomere, ultimately leading to
activation of ATM or ATR mediated DNA damage responses (194, 304), which explains
an observed activation of DNA damage signals during replication of telomeric DNA
(304).
When a replication fork stalls during replication at other chromosomal sites, the
stall is typically repaired by another replication fork coming from the opposite direction
meeting up with the stalled fork, at which point the two strands are joined through
recombination. This, of course, is not an option for telomeric sites where replication is
unidirectional. Stalls in telomere replication forks initiate a DNA damage response that
recruits the MRE11/Rad50/NBS1 complex to the site, because it is detected as a double
strand break (304). This complex then activates the Ataxia Telangiectasia Mutant (ATM)
and Ataxia Telangiectasia and Rad50 Related (ATR) damage responses. RPA protein
binds along the length of any exposed single stranded DNA. MRN, the 911 complex,
FEN1, DNA polymerase β, and Rad17 then cooperate to restart the replication fork
(reviewed in (304).) Replication through telomeres is thus observed to typically be a two
step process as observed by rate of BrdU incroporation: 1) Replication progresses into
the telomeric region and stalls and 2) replication fork reinitiates and progresses to the
end (304).

RecQ helicases are a conserved family in yeasts and mammalian cells that are
essential for maintaining genome integrity. These are critical for telomere replication and
resolution of telomeric recombination (10, 14, 66). Patients with defective Wrn helicase
specifically lose telomeres replicated by lagging strand synthesis, presumably due to
Wrn’s ability to unwind G-quadruplexes in a POT1 dependent manner (174, 234). Blm
helicase similarly functions to resolve these quadruplexes (234), and mutations to this
gene increase levels of sister-chromatid exchange, genomic instability, fragile telomeres,
and elevated levels of chromosomal aberrations (122, 123, 268). TRF2 seems to play a
role in stimulating Wrn/Blm activity (234). A heterotrimeric complex of proteins known as
RPA functions to bind to ssDNA during DNA replication and repair processes (316, 343).
Loss of RPA (or its homologues) in budding and fission leads to gradual shortening of
the telomeres (233, 276). In vitro models have shown that RPA is capable of stimulating
WRN’s ability to resolve G quadruplexes, modulates telomerase activity (235, 256, 280),
and coats ssDNA during the passage of the replication fork. However, Pot1 has a higher
affinity for the G-rich regions of the telomere single-strand overhang (10). An exciting
field of research is emerging to study a newly discovered RPA-like heterotrimeric
complex, the CST complex. This appears to be a key player in regulating C-strand
synthesis (215, 286). In both yeast and human cells, the CST binds to single-stranded
DNA and plays a role in mediating C-strand fill-in, regulates Telomerase (both positively
and negatively), and prevents excessive G-strand elongation (49, 215).
The role of TRF2 in aiding telomeric DNA replication is essentially through acting
as a protein hub (124, 157) and recruiting important replication and DNA maintenance
factors to critical sites. For instance, TRF2 recruits proteins like Apollo and Top2α to
locations of supercoiling strain to release tension during replication (4, 326). Additionally,
TRF2 localizes to sites of recombination and T-loop formation, where it then utilizes
factors like BLM and WRN helicase along with the MRE11/Rad50/NBS1 to resolve the

structures efficiently (4). Additionally, TRF2 localizes to the sites of the pre-replication
complex (pre-RC), where it interacts with the origin recognition complex (ORC) and
facilitates initiation of telomere replication (86, 292).

Telomere maintenance and Segregation
Telomeres play a vital role in ensuring the proper segregation and maintenance
of chromosomes during cell division, specifically meiosis. Significant research has been
conducted investigating telomere maintenance and meiosis of yeast. At the onset of
meiotic prophase I, telomeres attach to the nuclear envelope (NE) and undergo NEbound motility, attaching to the nucleoplasmic face of the inner nuclear membrane (46).
It has been proposed that the telomeres potentially connect to filament bundles that
project between the telomere attachment plate through the NE to the cytoplasm (178)
The telomeres then move along the inner nuclear membrane to the cytoplasmic
microtubule organizing center (MTOC) in animals and fungi (342) or the cell cortex in
plants (65)
Disruption of telomere maintenance proteins in eukaryotic cells lead to a number
of dysfunctions. Saccaromyces cerevisiae meiosis relies on scRap1. Strains with altered
telomere sequence or scRap1-binding sites experience defective meiosis (2, 193) Terc /- mice have reduced telomeric repeat tracks and defective axial element (AE) formation
and synapsis (182). Mammalian ring chromosomes, which don’t contain telomeres, don’t
localize to the nuclear periphery of spermatocytes (305).
Information on the proteins required for mediating the attachment to the nuclear
envelope is somewhat scarce, but the process seems to rely on the SUN domain
proteins (Sad1p, UNC-84 proteins that are important for positioning of the nucleus) which are
present in most organisms. SUN domain proteins bridge the gap between the inner and

outer nuclear lamina, connecting the nuclear and cellular cytoskeletons and playing a
role in organizing nuclear contents (300) SUN1 (96) and potentially SUN2, given that the
two typically have associated protein functions in NE protein attachment and
coordination (138).
Unfortunately, information on the role which telomeric proteins play during mitotic
chromosomal segregation is incomplete outside of some cursory studies. While it is clear
that telomeres play a role in ensuring the success of this process and regulating
telomeric recombination during meiotic pairing, a hard mechanism has yet to be defined.
TRF1 associated protein Tankyrase 1 (TANK1) is essential for separation of sister
chromatids during mitosis (99). Male mice missing the A-type lamin isoform C2, an
important protein linking the actin and microtubule skeleton to the nuclear envelope, fail
to undergo fine meiotic telomere/NE attachment and clustering (3). Nuclear envelopes of
frog oocytes contain a TRF2 homologue (247) that may provide a possible means by
which they attach to the envelope during meiosis. Rap1 is dispensable for formation of
the “bouquet” structure characteristic of chromosomal organization during cell division in
mammalian cells (260) but is required for the same process in Schizosachromyces
pombe (53, 154)

Homologous Recombination Based DNA Repair
Five distinct complexes exist to monitor for and repair DNA damage, of which the
ATM and ATR system are best characterized. Within the ATM system, DNA damage is
detected by the MRN complex, consisting of MRE11, Rad50, and NBS1. Once a break
is identified, the complex activates ATM and recruits it to the damage site (167). ATM
then phosphorylates a number of down-stream effectors to initiate the repair processes.
Over 700 proteins are phosphorylated in response to Ionizing Radiation damage (198).

Double strand breaks in DNA, particularly those caused by the introduction of ionizing
radiation, are repaired primarily by one of two mechanisms: the non-homologous end
joining (NHEJ) system and Homologous Recombination Repair (HRR) (42, 64, 289).
HRR is a primordial mechanism involving a complex series of events including: end
resection, Rad51 filament formation, homologous sequence identification, heteroduplex
formation, repair synthesis, and heteroduplex resolution [reviewed in (125)]. This repair
mechanism can only function during S and G2 phase, when DNA has been replicated
and the sister chromatid is available for recombination. Approximately 15% of ionizingradiation induced DSBs are repaired by HRR (153).
Regulation of the HRR system is complex and redundant. The identification of a
DSB in a chromosome is followed immediately by phosphorylation of ATM (17). This
phosphorylation is required for recruitment of ATM to the site of the break and is 90%
efficient, but is not required for successful repair (315). ATM is thus alternately described
as either a director sensor of DSBs and mediator of repair or an indirect sensor that
promotes cell survival and repair. ATM then functions to phosphorylate a number of
downstream factors at the repair site to activate the repair processes including Chk2,
BRCA1, and γH2AX(56, 139). ATM activation is also required for differentiation
dependant amplification (218).
The primary indicator of DNA damage in cells is the phosphorylated forms of γphosphorylated Histone 2AX (γH2AX) (45, 108, 284). Another factor phosporylated by
ATM is MDC1 (mediator of DNA-damage checkpoint 1), which recruits a number of HRR
factors including 53BP1 and BRCA1 (113, 228). Another key factor is the NMD complex
of proteins, consisting of MRE11, Rad50, and MRN. MRE11 is a single ssDNA
endonuclease and possesses 3’-5’ endonculease activity (299). Rad50 is an ATPase
(148). MRN contains a DNA end binding domain. Together, these proteins rapidly locate

sites of DNA damage independent of ATM activation and helps recruit factors to initiate
the repair processes (212). Additionally, the MRN complex actually promotes recruitment
of ATM to damage sites and increases its autophosphorylation (108, 167, 168).

DNA Repair Systems Targeted To Telomeres
The interplay between the telomere maintenance proteins and the cellular DNA
repair systems is intricate and vital, since loss of these systems leads to rapid activation
of NHEJ, telomere loss and/or end-to-end fusion of chromosomes. Formation of the TLoop at the telomeric end is an important part of this process, as it inhibits the activity of
DNA liagase IV, the enzyme responsible for fusing telomeres (77). TRF2 is obviously
vital for this, as it is responsible for forming the T and D-loop structures along with POT1.
TRF2 is thus required for blocking recognition of telomeres as ds-DNA breaks.
Interestingly, a number of DNA repair factors localize to the telomeres through a
direct interaction with TRF2 (278) and a body of evidence is available to demonstrate
that the telomere maintenance systems in general and TRF2 in particular play an
important positive role in DNA repair. Conditional deletion of TRF1 and 2 to remove the
shelterin complex leads to derepression of 6 different repair pathways: ATM, ATR, CNHEJ, HDR, alt-NHEJ, and 5’ resection (267). The basic domain of TRF2 allows the
protein to localize to double stranded breaks induced by UV light (40) irrespective of the
presence of TTAGGG repeats, as well as Holliday junctions (116). This makes some
sense, given that TRF2 is important for initiating a telomerase independent method of
telomere maintenance known as ALT which relies heavily on recombination based
methods to regulate telomere length (281). This ALT system relies on TRF2 mediated
formation of ALT Mediated PML Bodies (APBs) that contain MRE11, NBS1, Rad50, and

PML components. A form of this can be observed in vitro, as it has been found that
telomere repeats can recruit PML through a SUMO dependant mechanism and initiate
non-replicative DNA synthesis (55).
Indeed, TRF2 appears to play a vital, but as-yet unclear role in activating DNA
repair systems. In response to DNA damage such as double strand breaks, PI-3Kinases like ATM rapidly phosphorylate Thr-188 of TRF2, triggering it’s relocation from
telomeres to the sites of DNA damage (40, 150, 291). Phosphorylated TRF2 leads to
increased survivability of cells after X-Ray induced DNA damage, apparently by initiating
the Fast DNA repair response and altering the kinetics of H2AX phosphorylation (150).
Contradictorily, TRF2 inhibits ATM activation (155) possibly suggesting a feedback
mechanism to regulate ATM activation and TRF2 phosphorylation. TRF2 has been
shown to inhibit NHEJ and upregulate the HRR system (195). As such, loss of TRF2
leads to activation of ATM kinase, the p53 tumor suppressor signaling pathway, and the
MRE11 double-strand break repair system. This leads to induction of cellular
senescence or apoptosis (47, 84, 107), activation of NHEJ, interchromosomal fusions,
(302) and can lead to telomeres being fused to other double-stranded breaks at nontelomeric sites. This can ultimately lead to chromosomal translocations (130). Loss of
Pot1, additionally, leads to activation of ATR kinase, formation of telomere dysfunctioninduced foci, and induction of apoptosis or cell cycle arrest (84, 146). Sudden large
deletions of over-elongated yeast telomeres have been observed as a result of
resolution of the t-loop as if it were a Holliday Junction, underlining the need for strict
regulation of the extent to which t-loops form (190).

Telomere Replication and Maintenance with viruses
Telomere maintenance and DNA repair proteins play an important role in the lifecycle of numerous DNA viruses that utilize a long-term stability strategy. Many DNA
viruses utilize similar replication and maintenance strategies to HPV. Epstein Barr Virus
(EBV), Kaposi’s Sarcoma Herpesvirus (KSHV), Herpesvirus saimiri (HVS), and gammaherpesvirus68 (MHV-68) all have a chromosome tethering strategy (reviewed in (201).)
In addition, a number of other interactions between DNA viruses and the DNA repair
systems have been demonstrated. HSV 1, EBV, and SV40 recruit Rad51 to replication
compartments (35, 165, 314).
Initially, an interaction between the Epstein Barr virus and the telomere
maintenance system was demonstrated by the laboratory of Dr. Paul Lieberman(325).
One region of the EBV genome is the plasmid origin of replication, the OriP, which
consists of the dyad symmetry region (DS) and the family of repeats (FR). Plasmids
which contain the OriP alone are capable of stable replication and maintenance of
plasmids in mammalian cells in the presence of the EBV Nuclear Antigen 1 (EBNA1) , a
factor which is required for viral genome maintenance during latency (325). EBNA1 as
well as KSHV LANA protein are structural and functional homologues of HPV E2,
possessing a unique anti-beta barrel DNA binding structure (34, 136). The DS to
contains 4 sites of nine-base telomeric repeat DNA in the dyad symmetry region, similar
to those found in the late region of HPV. These repeats are required for DNA replication
(225) and plasmid maintenance (225, 325). These telomeric repeats also allow binding
of TRF2 (87), which is required for plasmid replication and maintenance (87, 323). It’s
believed that one important function of TRF2’s role in OriP replication is recruiting the
proteins of the Origin Recognition Complex (ORC). TRF2 interacts with EBNA1 (169),

and this interaction is required for the replication and maintenance effect (85, 87). These
processes can be inhibited by overexpression of a TRF2 dominant negative plasmid with
the N and C terminal domains deleted (85). Another important role of TRF2 is to recruit
the Origin Recognition Complex (ORC) to the DS (13). Other studies demonstrated that
the MRN repair complex, which consists of MRE11, Rad50 and NBS1, interact with the
OriP plasmids in a TRF2-and-cell-cycle-mediated manner, and this interaction has an
effect on OriP plasmid stability (92). Loss of NBS1 or MRE11 leads to loss of episomal
maintenance of EBV genomes in certain lymphocyte cell lines (92). Replication at the
OriP was shown to involve formation of recombination-like structures similar to Holiday
Junctions during S-phase by 2D Gel electrophoresis.
KSHV also encodes a structural and functional homologue of the HPV E2 and
EBV EBNA1 proteins, Latency Associated Nuclear Antigen (LANA.) LANA is responsible
for latent phase DNA replication, gene expression, and segregation, again similar to the
E2 and EBNA1 proteins (20). A study performed by the Renne laboratory demonstrated
that, along with thirty other proteins, TRF2 associates with a seventy base pair minimal
replication element from the KSHV genome (149). Additionally, a number of DNA repair
proteins, including Ku70, PARP-1, and DNA-PK associates with this minimal repeat
element (270). LANA co-immunoprecipitates with TRF2, but interestingly only when
cotransfected with a plasmid containing an intact, wild type copy of the RE. Unlike
results observed in EBV, no nanomer telomere repeats were found in the KSHV RE, and
co-transfection of the RE plasmid with the TRF2 dominant negative mutant did not result
in a significant change in plasmid replication compared to negative control. The study did
not, however, examine what effect loss of TRF2 function would have on plasmid
segregation, or if siRNA knockdown of TRF2, rather than overexpression of the
dominant negative, would have an effect on plasmid replication.

Some telomeric factors are associated with papillomaviruses. The most obvious
example of this is the activation of telomerase expression in cells due to E6 expression
(163, 303). One possible explanation of this is that hTert can substitute for E6 in E6/E7
mediated immortalization of human foreskin keratinocyte cells (162), indicating that
telomerase activation is an important component of HPV maintenance. ChLR1, a DNA
helicase involved in sister chromatid cohesion, is an E2 interaction partner that has been
shown to be required for extrachromosomal maintenance of BPV1 genomes (239).

HPV and HRR
Papillomaviruses, like many other low-copy number DNA tumor viruses interact
with and utilize components of the DNA repair systems, particularly the homologous
recombination repair system. HPV31 was shown by Liu Laimins’ laboratory to activate
ATM during the course of its replication within cells, partially due to expression of E7
(218, 252, 314). E7 binds to ATM and the MRN complex. ATM activation is also required
for genomic amplification but not stable maintenance replication (218). A number of
studies have demonstrated that several downstream ATM DNA repair factors are
recruited to HPV replication foci (125, 218, 251, 255, 287). HPV31 replication in
keratinocytes increases γH2AX and 53BP1 levels and leads to recruitment of these
proteins to replication foci. γH2AX specifically binds to the URR of HPV31. A separate
study has demonstrated that a similar increase in γH2AX occurs with expression of E1
from HPV18, 16, 11, and 6B, indicating this is a broad feature of HPV replication, and
that co-expression of E1 and E2 activates DDR (251). Comet assays have indicated that
E1 and E1+E2 complexes induce double stranded DNA breaks. The ATPase and DNA
melting functions of E1 are required for this process, while the sequence specific DNA
binding function of E1 and E2 are dispensable, suggesting an alternate means of

initiating the DNA damage and implying that E2’s primary function in this role is in
stabilizing E1. Interestingly, inclusion of an HPV origin-containing plasmid reduced the
DNA damaging activity of E1, suggesting that the presence of an HPV origin may alter
the E1 protein’s function.
pATM, BRACA1, RPA, Rad51, ATRIP, TopBP1, and Chk2 are also recruited to
HPV replication sites, and the amount of these factors increases as differentiation
progresses in the cells (125, 251). As an increase in differentiation leads to an increase
in replication of the HPV genomes, it has been theorized that the DNA repair factors are
recruited to the newly synthesized copies of HPV within these foci. This is supported by
the gradual increase in levels of activated RPA, which binds to single stranded or newly
synthesized DNA. Interestingly, however, activation of ATM and Chk2 signaling appear
to be dispensable for transient as well as maintenance replication (218, 251), leaving the
question of just what role these processes play in HPV DNA replication.

Specific Aims
The objective of my research was to examine the relationship between human
papillomaviruses and their host cells during the maintenance phase of their viral life
cycle. During this phase, the virus only expresses E6 and E7 to an appreciable level in
infected cells and is highly reliant on the host cell to provide the factors required for viral
genome replication and maintenance. DNA viruses which rely on a long-term replication
strategy in cells traditionally co-opt some or all elements of the DNA repair and,
discovered more recently, the telomere maintenance systems to provide these functions.
We thereby utilized bioinformatic, molecular, and cellular methods to investigate the
interaction between papillomaviruses and their host cells, particularly through the E2

maintenance protein and its interactions with the telomere maintenance and DNA repair
systems, with an aim to better understand the factors which provide long-term stability
for HPVs.
Specifically, we utilized bioinformatic analysis to investigate the evolution of the
E2 protein and binding sites as papillomaviruses evolved to infect a wider range of hostspecies and tissue types.
Secondly, through our well-established yeast replication system, we performed
experiments to determine which papillomaviruses share the ability to replicate in
Saccharomyces cerevisiae and to potentially shed light on what common sequence
features are important. Through this study, we determined that a number of
Papillmavirus species are not capable of replicating stably in yeast, particularly BPV1,
which had previously been identified as being capable of replicating short term.
Finally, we investigated the interaction between TRF2 and HPV16 . Upon
identifying the presence of nine base telomere repeat sequences in the late region of a
number of HPVs, we sought to determine if these were necessary for HPV maintenance.
We utilized a Chromosome ImmunoPrecipitation (ChIP) assay to show that these
sequences were bound by telomeric and some DNA repair proteins in vitro. We showed
that in both yeast and mammalian cells, deletion of these binding sites led to an overall
loss in stability ranging from slight shifts in copy number to complete loss of plasmid
viability. Through a number of methods, we demonstrated that TRF2 interacts with the
viral E2 protein, as do a number of other telomere maintenance proteins. Finally, we
took steps to demonstrate the co-localization of the proteins within cells.

Chapter 2
Evolutionary variation of papillomavirus E2 protein and E2 binding sites
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Abstract
In an effort to identify the evolutionary changes relevant to E2 function,
within and between papillomavirus genera, we evaluated the E2 binding sites (E2BS)s
inside the long-control-region (LCR), and throughout the genomes. We identified
E2BSs in the six largest genera of papillomaviruses: Alpha, Beta, Gamma, Delta,
Lambda, and Xi-papillomaviruses (128 genomes), by comparing the sequences with a
model consensus we created from known functional E2BSs (HPV16, HPV18, BPV1).
We analyzed the sequence conservation and nucleotide content of the 4-nucleotide
spacer within E2BSs. We determined that there is a statistically significant difference in
GC content of the four-nucleotide E2BS spacer, between Alpha and
Deltapapillomaviruses, as compared to each of the other groups. Additionally, we
performed multiple alignments of E2 protein sequences using members of each genus in
order to identify evolutionary changes within the E2 protein.
When a phylogenetic tree was generated from E2 amino acid sequences, it
was discovered that the alpha-papillomavirus genus segregates into two distinct
subgroups (α1 and α2). When these subgroups were individually analyzed, it was
determined that the subgroup α1 consensus E2BS favored a spacer of AAAA, whereas
subgroup α2 favored the opposite orientation of the same spacer; TTTT. This
observation suggests that these conserved inverted linkers could have functional
importance.

Introduction
The E2 protein serves many functions with its primary role being that of a
transcriptional regulator. E2 is a negative regulator for the expression of the oncogenes
E6 and E7 (184). E2 polypeptides contain three probable domains: a DNA binding
domain (DBD) located at the C-terminus, an N-terminus transactivation domain, and an
internal “hinge” domain. Both the C-terminal and N-terminal domains are relatively well
conserved within the PVs (254). E2 binds as a dimer at DNA-binding sites and this
action is mediated through the DBD (202). The E2 DBD forms a dimeric β-barrel and
each strand contributes a half-barrel. The dimer interface has a hydrophobic core and
uses extensive hydrogen bonding between subunits to maintain tight binding. This βbarrel core contains elaborately packed side chains that contribute to the stability of the
dimer. There is a poorly conserved loop connecting β-strands 2 and 3. This loop varies
from 6-10 residues. The tertiary structure of characterized E2 DBDs is similar, but there
appears to be variation in the orientations of the two subunits (141). There is some
evidence to suggest that the activation domain mediated oligomerization could influence
interaction between E2 molecules bound at distant E2-binding sites forming DNA loops
and other DNA structures (8, 141).
The consensus sequence 5’-ACCgNNNNcGGT-3’ is recognized by E2, with the
position 4 and 9 residues allowing some variability. A number of studies have been
performed to examine the binding of E2 protein to its cognate binding site (33, 83, 111,
141, 144, 249, 257, 293). The 4-nucleotide spacer sequence varies by HPV type, and
has been identified as being critical for determining E2 binding affinity through indirect
readout as well as playing a potential role in gene regulation, despite having no
predicted nucleotide-amino acid contacts from crystal structure (33, 83, 141, 144, 328).

E2 binds DNA as a homodimer with each monomer supplying an alpha helix to contact
two successive major grooves of the target site (83, 141)
Four typical E2 binding sites are conserved in the upstream regulatory region
(URR) of most papillomaviruses numbered according to their distance from the early
promoter (202). Each site is differentially regulated and demonstrates variable binding
affinity for the E2 protein, resulting in varying replication and transcriptional effects
during the viral life cycle (63, 191) presumably as a result of differences in E2 binding
affinity (141) due to sequence variation as well as methylation of the E2 binding site
(257, 293). These binding sites are typically well conserved across all papillomaviruses.
However, in some cases variation in the number and location of some E2 binding sites
does exist, including a predicted fifth binding site within the URR of betapapillomaviruses
(103) and some alphapapillomaviruses (257) as well as observation of up to 17
sequences with ability to bind E2 from the URR of bovine papillomavirus 1 (249).
In this study, we examined the evolutionary divergence in E2BS recognition by
the E2 transcriptional regulatory protein. Currently, the majority of the work performed on
the E2 protein function has been performed on domains from a relatively small number
of papillomavirus types. To better understand the binding properties of E2 from a wide
spectrum of HPV strains, we performed an observational study in which we used
bioinformatic tools to generate a list of putative E2BS sequences matching the
consensus in all papillomaviruses currently classified by ICTV and analyzed them for
variations in binding site number, location, and differences in the 4-nucleotide spacer
region between the largest of the HPV genera, the Alpha, Beta, Gamma, Delta, Lambda,
and Xipapillomaviruses. We then performed multiple alignment and phylogenetic
analysis using the E2 amino acid sequences of these viruses to observe evolutionary
patterns from an E2-Centric perspective. Finally, we performed sequence alignment of

the viral E2 protein C-terminal DNA binding domains of each genus and observed that a
greater degree of variation is present in the Alphapapillomaviruses compared to Beta. As
one of the characteristics associated with the classification of papillomaviruses into their
respective genera includes the ability to infect mucosal and cutaneous epithelia as well
as fibroblast tissue, we propose that evolution of the E2 protein and its cognate binding
site correlate with the adaptive radiation papillomaviruses underwent during the course
of evolving to infect new tissue types.

Materials and Methods
Putative E2 Binding Site Identification and Analysis
Initially, we obtained sequences for the confirmed E2 binding sites from three
representative, well-characterized papillomavirus species, HPV16, HPV18, and
BPV1(141, 176), to create a broad, complete representative training data set. We then
utilized Multiple EM Motif Elicitation (MEME) software to use statistic modeling
techniques to create a consensus motif sequence for E2 binding sites within the
genomes of papillomaviruses(15). This motif was then used to search through all
complete papillomavirus sequences (obtained from the Papillomavirus Episteme (PaVE)
database containing information from Refseq and Genbank (1, 232, 248)) for all
papillomavirus genera containing 5 or more members (HPV 2-40, 42-45, 47-62, 65-78,
80-96, 99, 100, 102, 104-107, 110, 111, FA75/KI88-03, RTRX7, BPV1-9, COPV, DPV,
FdPV1, FdPV2, LrPV1, PlpPV1, PcPV1, UuPV1, and MfPV1-10, utilizing the Motif
Alignment and Search Tool (MAST)(16). For later phylogenetic analysis of
alphapapillomavirus subgroups, we divided our data set to into high and low risk groups
and alphaPVs capable of infecting cutaneous keratinocytes. The high risk group

included HPV 16, 18, 26, 31, 33, 35, 39, 45, 52, 56, 58, 59, 67, 73, and 82. The
cutaneous subgroup included HPV2, 3, 10, 27, 28, 29, 57, 78, and 94.
E2BS Sequence Analysis
After retrieving the list of putative E2BSs from the ICTVdb papillomavirus
sequences, the data was sorted based on a number of criteria. Recovered sequences
were manually analyzed from the resultant MAST output to observe the genome location
of the identified binding sites as well as the GC content of the four base spacer
sequences. Binding sites were classified as either within or outside the LCR according to
the criteria of being located between the end of the L1 opening reading frame and the
beginning of the E7 open reading frame. Binding sites were similarly separated into their
respective papillomavirus genera and the identified E2BSs were analyzed using MEME
to generate a SequenceLogo to observe the consensus E2BS sequences for each
papillomavirus genus. Similar MEME analysis was performed to compare the E2BSs of
low and high risk alphapapillomaviruses.
Protein Sequence Alignment
Amino acid sequences for all known E2 proteins within the papillomaviridae
family were acquired from NCBI and sorted into the respective papillomavirus genera
analyzed in 2.1 and 2.2. To increase the significance of results, analysis was limited to
the alpha and betapapillomavirus genera, as the other genera possess less than ten
members each. All E2 sequences were then aligned using Muscle (100). Some
sequences (HPV77, 3, and 29) were removed due to long stretches of non-homologous
repetitive DNA in the linker region. Alignments were then repeated, focusing specifically
on aligning the amino acids located within the C-terminal DNA binding domain of E2.

Weblogo was then used to generate a graphical representation of the sequence
alignments.
Phylogenetic Analysis
We performed phylogenetic analysis to examine evolution of papillomavirus E2
amino acid sequences. Complete amino acid sequences were obtained from NCBI for all
papillomaviruses analyzed in 2.1 and subjected to multiple alignment using COBALT
software (238). The multiple alignment was then used to draw phylogenetic trees using
Neighbor Joining and Kimura protocols.

Results
E2BS Identification
To examine the evolution of the E2 DNA binding site (E2BS) sequence, we
utilized the sequence motif analysis software Multiple EM Motif Elicitation (MEME) to
generate a consensus DNA binding site. Initially, we generated a training set based on
the confirmed E2 binding sites from HPV16 and 18 as well as BPV1, as these are well
characterized and representative of the papillomavirus family. The resulting binding site
motif Sequence Logo is shown in panel 2.1A, demonstrating the high conservation of
bases from positions 1-3 and 10-12. As expected, little sequence conservation from the
four base spacer region was observed. Genome sequences were collected from ICTVdb
(248) and sorted into the various papillomavirus genera. Papillomavirus genera were
eliminated from the rest of the analysis if they contained less than five members to
improve the statistical significance of results. In total, 68 alpha, 35 beta, 6 delta, 7
gamma, 7 lambda, and 5 xipapillomaviruses were analyzed, totaling 128
papillomaviruses (111 human and 17 animal sequences). These were then used to

identify the location of E2 binding sites utilizing MAST software to identify DNA
sequences with high sequence identity to the MEME generated binding site motif.
As expected, the four conserved binding sites located within the URR were
identified in the majority of papillomavirus species examined (data not shown.) However,
a number of additional potential E2 binding sites were identified within and outside of the
URR. The number of E2 binding sites identified averaged between four and six per
genome for the alpha, beta, gamma, lambda, and xipapillomaviruses, whereas the delta
papillomaviruses averaged eight binding sites per genome, (Fig 2.1B) due in large part
to the 14 E2BSs identified in BPV1. The majority of these sequences were located within
the URR as expected, averaging approximately 3 for the alpha, beta, gamma, lambda,
or xi, and 7 for delta.
E2BS Sequence Analysis
The identified E2 binding sites were then collected and examined to identify the
GC content of nucleotides located within their four base spacer regions. G and C
nucleotides from the observed E2BSs were counted and tabulated to obtain the average
GC content of the four nucleotide spacer. Most cutaneous papillomavirus genera
contained approximately 25 to 30% GC content within the spacer region (Fig. 2.1C).
Alphapapillomaviruses in general tended to have very low GC content (15%) and
deltapapillomaviruses tended to be very high (approximately 50%, indicating no
statistical preference for GC versus AT bases.)
When E2BSs were sorted into “within the URR” and “outside the URR” groups,
certain trends became apparent. First, alphapapillomaviruses and to a lesser extent
xipapillomaviruses seemed to have a unique requirement for AT nucleotide rich spacers
within the URR and a much higher GC content in E2BSs located outside. Gamma and

lambdapapillomaviruses seemed to possess an opposite trend, with a 15-18% GC
content outside the URR and significantly higher found inside. Deltapapillomaviruses
tended to have a much higher GC content within the spacer than the other
papillomavirus genera, while the betapapillomaviruses was approximately 30% GC rich.
To further this analysis, we performed MEME analysis on the identified E2BSs
for each papillomavirus genus to identify sequence variation binding sites by genus (Fig.
2.1D). As expected, nucleotides 1-3 and 10-12 were well conserved across
papillomavirus genera. Some variation was observed in the preference for C and G
nucleotides at positions 4 and 9 respectively, particularly in the gamma and delta genera
at position 9. The four nucleotide spacer is, as expected, highly variable between
papillomavirus genera, however some trends are apparent. Alpha papillomaviruses
seemed to have the most consistent sequence conservation, particularly at positions 5-7
where A nucleotides were highly conserved. A and T bases were overrepresented in all
papillomavirus genera except deltapapillomaviruses. Despite little evidence of evolution
of contact nucleotides, we observed that each of the papillomavirus genera seem to
have varying preferences for binding site spacer sequences.
E2 Protein Phylogenetic Analysis
To examine E2 evolution from a protein perspective, we acquired amino acid
sequences for all the E2 proteins from papillomaviruses used for the E2BS analysis. The
E2 sequences were then analyzed using COBALT software under Neighbor Joining and
Kimura protocols. The resultant phylogenetic tree is shown in Figure 2.2A. As shown,
when analyzed simply from E2 amino acid sequences, papillomaviruses sort into specific
clades matching with the official genera classifications which, as stated previously, were
based on L1 amino acid sequences (81)

Three specific clades become apparent based on this analysis: one containing
the deltapapillomaviruses, one containing the alphapapillomaviruses, and a third
encompassing the other genera analyzed. The delta clade possessed a large degree of
evolutionary distance compared to the other clades from the COBALT analysis, implying
a significant evolutionary divergence in terms of the E2 protein from the other
papillomaviruses. One papillomavirus, FDPV2, did not sort out with the other members
of the lambdapapillomavirus genus and did not associate with any of the other clades
identified by this analysis.
The alpha clade further subdivides into two subclades, in this study labeled as α1
and α2. When analyzed independently, specific trends were identified for these two
subclades. The individual members of the subclades possess specific infectious
characteristics (Fig 2.2b). The majority of the human papillomaviruses from subclade α1
are considered to be high risk for progression to cervical cancer. While they do not
cluster together particularly well within the subclade, one subclade contains both HPV16
and HPV31, two of the papillomaviruses that are most associated with cervical cancer.
Interestingly, subclade α1 also contains a cluster of viruses infecting longtailed and
rhesus macaques, which seems to have diverged less than the other members of the
subclade (Fig 2.2A). Subclade α2 contains two clusters of alphapapillomaviruses
capable of infecting cutaneous keratinocyte cells as well as three clusters associated
with large genital warts.
MEME Analysis of Alpha Subclade E2BSs
Given the results of the phylogenic analysis for the alphapapillomavirus genus,
we performed MEME analysis on the identified E2BSs for each of the
alphapapillomavirus subclades, as well as those papillomaviruses classified as high and

low risk of progression to cancer and the two clusters containing the
alphapapillomaviruses capable of infecting cutaneous keratinocytes (Fig. 2.2C.) Given
that subclade 1 primarily contains high risk viruses, the consensus motif for alpha
subclade1 and high risk alphapapillomaviruses are essentially identical. No significant
difference was apparent between the high risk and low risk viruses outside of a slight
under-representation of the guanine nucleotide at position 4 which could, potentially,
suggest reduced susceptibility at this site for methylation (see discussion). Cutaneous
papillomaviruses possessed a significantly reduced preference for A/T nucleotides within
the four base spacer. Interestingly, the subclade 2 consensus motif appears to contain a
preference for bases within the four base spacer of thymine rather than adenine. Given
that the E2BS sequence is a pseudo-palindrome, this implied that the consensus motif
for clade 2 is an inversion of the motif from clade 1.
E2 Amino Acid Sequence Conservation
One of the primary differences between alpha papillomaviruses and the other
genera is the ability to infect mucosal versus cutaneous keratinocytes. Consequently,
we examined whether a similar level of divergence existed in the amino acid sequence
of the protein itself. In order to demonstrate evolutionary divergence of human
papillomavirus E2 proteins, we first obtained complete amino acid sequences for all the
Alphapapillomaviruses and a representative genus of cutaneous papillomaviruses, the
Betapapillomaviruses. Other papillomavirus genera were excluded, as these respective
groups averaged less than ten members, thus the alignments could not be considered
reliable. We initially performed sequence alignments on the entire protein. However, it
was determined that the linker region of Alphapapillomavirus sequences, which is not
well conserved within the HPV respective types, was skewing the results of the
alignments (data not shown). We therefore adjusted our sequences to contain only the

C-terminal 80 amino acids of the E2 protein, which roughly corresponded to the DNA
binding domains (DBD) (Figures 2.3A, 2.3B). It is immediately apparent that
Alphapapillomaviruses seem to have a great degree of sequence diversity relative to
Betapapillomaviruses. A series of representative alignments obtained an average
sequence identity of 41% for Alphapapillomaviruses when compared to 65.25% identity
for Betapapillomaviruses. The differences were also apparent when the logos
representative alignment program was used to generate a consensus sequence (Figures
2.4A, 2.4B) even within the well-conserved region of amino acid sequence that makes
direct contact with the nucleotides of the E2BS.

Discussion
The vast majority of papillomaviruses analyzed using MEME and MAST during the
course of this study conform to the expected number and location of the four conserved
E2BSs within the URR of their genome, with some variations in individual strains. The
averages across all the genera were between 4-6 E2BSs, outside of the
Deltapapillomavirus genus which was contained significantly more. The majority of the
sites identified from the study were located within the URR, as expected, though in some
cases sequences that have the potential to be bound by E2 protein were identified within
the papillomavirus coding sequences. Whether these putative downstream E2BSs are
actually occupied during active infection is an open question but could, presumably,
significantly impair the expression of the ORF the binding site is located within by
blocking the progress of RNA polymerase.
Papillomaviruses are classified by their tissue tropism, genome organization, and
sequence divergence in a conserved region of the L1 open reading frame (82).
However, recent phylogenetic analyses have demonstrated that alignment based off of
the E1 and E2 protein sequences results in a phylogeny which better clusters

papillomavirus species in terms of their epidemiology and oncogenicity (176). The E2
protein is one of four genes which are present in all known papillomaviruses, but has the
highest DN/DS ratio of the four, or ratio between nonsynonymous versus synonymous
substitutions (223). This is not surprising because E2 plays numerous functional roles in
the cell. For example, E2 regulates transcription, facilitates DNA replication, and
regulates viral genome maintenance (202). It is logical, then, that E2 would be under
significant evolutionary pressure to adapt to new cellular environments.
E2 proteins bind a consensus palindromic sequence ACCgNNNNcGGT through
a dynamic, water mediated interface (111, 141). The NNNN central region or “spacer” is
conserved in length, but the sequence varies by species and individual binding site
position. Hierarchical occupation of the E2BS by the protein has important functional and
regulatory consequences for both transcription and replication during infection. Previous
studies have shown that A:T-rich spacers have an increased binding affinity in certain
papillomavirus species (141, 202). Specifically, while some Alphapapillomaviruses like
HPV16 are acutely sensitive to AT concentration in the spacer region, others like BPV1
are essentially insensitive. Hegde et. al. proposed that the reason for this is due to a
reduced ability possessed by the E2 protein of some Alphapapillomaviruses, specifically
HPV16, to bend DNA into a conformation which fits within the E2 DNA binding pocket
(141). Essentially, AT rich nucleotide motifs are intrinsically rigid and pre-bent into a
shape that conforms to the E2 protein DNA binding domain. The results of this study
support the concept that Alphapapillomavirus E2BSs possess approximately 95% A/T
nucleotides within the spacer region, but only 75% in the cutaneous papillomavirus
genera, and 50% in Deltapapillomaviruses. With the current limited understanding of
nucleotide sequence recognition, specifically for indirect readout which occurs in regions
like the E2BS spacer where no direct nucleotide-amino acid contacts are made,

predictions of binding affinity are limited to sophisticated bioinformatic modeling software
and empirical data identified using methods like quantitative EMSA. However, regions of
increased positive charge tend to correlate favorably with DNA deformation ability,
presumably through non-symmetrical charge neutralization by interactions between
positively charged amino acid residues and the negatively charged phosphate backbone
(285) or by actively attracting the negatively charged DNA to positive residues (156).
Observation of alignments of the Alpha and Beta HPV E2 DNA binding domains (Figure
3, 4) appear to support this assertion, as a greater number of conserved positivelycharged amino acid residues, both within the nucleotide contact region as well as
outside, were present in the Betapapillomaviruses. This observation correlates with the
increased presence of GC residues in the spacers of Betapapillomavirus E2BSs.
Additionally, a cluster of positively charged residues located c-terminal from the DNA
interaction region has been implicated in providing the relative insensitivity to spacer GC
content observed with the BPV E2 protein (141). Interestingly, we observed that the
consensus MEME motif diverged even within distinct papillomavirus genera. Specifically,
the two alpha subclades’ consensus binding site possessed an inverted four base
spacer. Typically, when the four conserved binding sites are observed individually, the
spacer of binding sites 5’ of the viral origin of replication tend to be oriented such that the
consensus binding site possesses A nucleotides whereas those 3’ of the ori contain the
inverse, or T nucleotides(257). As a result, given that the E2BS sequence resembles a
palindrome, this would likely result in the E2 protein binding in opposite orientation. The
functional consequences of this have yet to be fully explored, but may have significant
biological implications.
Within the viral genomes of the respective strains, divergence of E2BS locations
correlated with tissue type that was infected by the respective strains. This may have

effects on viral transcriptional regulation. There are 4 primary conserved binding sites
near the viral origin of replication termed BS1, BS2, BS3 and BS4. E2 binding to the first
site (BS1) interferes with TATA box recognition by the TATA binding protein, binding to
the second (BS2) and third (BS3) sites causes promoter repression by competition with
cellular transcription factors and binding to the fourth site (BS4) up regulates viral early
gene expression (141). In addition, binding to BS3 is necessary for DNA replication.
When E2 protein concentration is low, the promoter for the E6 and E7 oncogenes is
activated and BS4 is occupied. When E2 protein concentration is high, the E6 promoter
is repressed and BS1 and BS2 are occupied by E2 (141). Differential affinities for the
spacers of these E2BSs have been predicted to play a regulatory role in E2 mediated
viral gene transcription (141). The vast differences in number and location of E2BSs
identified in this study, however, would seem to suggest that there may be significant
differences in this from one virus species to another. Additionally, the E2 proteins of
individual papillomaviruses have demonstrated variable ability to tolerate GC content of
the four base spacer(141) and binding site methylation(257) may further individualize the
specific regulation strategy utilized by each.
All four of the E2BSs in the LCR are almost exclusively AT rich. However, predicted
E2BSs outside the LCR generally contained higher levels of GC content. This suggests
that these binding sites would tend to have much lower binding affinity for E2.
Considering that external binding sites were not conserved between various HPV types
and the fact that E2 has numerous functions that are up or down regulated during the
course of the viral life cycle, it is difficult to speculate what roles these additional binding
sites might play, including remodeling the chromosome structure or potentially blocking
the progress of RNA polymerase complexes during the coding process. Further
complicating the issue is the fact that, in BPV1, 17 total E2 binding sites have been

previously identified by gel shift assay, many of which had significantly divergent
sequences from the consensus (175). However, the study also determined that the
binding sites that were more closely related to the consensus generally had the highest
binding affinity for E2, so it is likely that the binding sites identified from this study are
preferentially filled at more stages of the viral life cycle. This presents a possible
regulatory mechanism to control occupation of E2BSs and thus their transcriptional
and/or replication effect.
One explanation for the greater degree of variability in mucosal HPVs could stem
from the wide tissue types infected by Alphapapillomaviruses. Much of the evolutionary
differences observed in the study correlate with differences in preferred infection site.
Mucosal epithelia infected by Alphapapillomaviruses ranges from oral to anogenital, all
of which could provide a slightly different environment for HPV replication. Additionally,
while cutaneous tissue tends to be relatively isolated from the immune system, mucosal
epithelia is much more actively surveyed by the immune system and exposed to IgA.
This could also potentially serve as a driving force for differentiation in E2 protein
function. Previous work has established that differences in tissue type can have
significant effect on LCR transcription enhancer activity (213, 253). E2-host co-evolution
could then be a potential explanation for the extreme level of tissue specificity exhibited
by most members of the papillomaviridae family.
In general, GC content tends to be low in papillomaviruses, presumably as a means
of eliminating targets for methylation by the host gene regulation machinery (257).
Sanchez et. al. determined that there was an evolutionary selection for CpG methylation
sites within the E2BSs of papillomaviruses at positions 4-5 and 9-10(257). Our analysis
demonstrated a varying prevalence of G and C nucleotides, respectively, at these sites
between the papillomaviruses. Beta and Xipapillomaviruses both possessed a much

higher prevalence for CpG methylation site at one or more of the potential sites
compared to the average for the other genera. Deltapapillomaviruses seemed to favor
the presence of a methylation site at the 4-5 position but not at the 9-10 position. For
other papillomaviruses, the patterns are somewhat more ambiguous, which is consistent
with a previous study (257, 293). As such, if the same holds true for other
papillomavirus genera, it is expected that, as our results come from a combination of all
the E2BSs, this pattern would be somewhat skewed. A similar effort to examine the
individual conserved E2BSs for papillomaviruses beyond the alpha genus would
possibly determine if similar methylation patterns exist, but is beyond the scope of this
study.
One important observation from this experiment is the large degree of variability
between both the proteins and their counterpart DNA binding sites between
papillomavirus genera. Deltapapillomaviruses averaged a larger number of E2BSs within
the URR (skewed somewhat by the 17 reported E2BSs in BPV1) than any of the other
genera examined in this study, and demonstrated a large degree of insensitivity to GC
content in the 4 base spacer region. Conversely, the Alphapapillomaviruses showed a
preference for A/T nucleotides within the four highly conserved E2BSs in the URR,
almost to the point of exclusion at some base positions. The other genera ranged
somewhere in between. It’s tempting to infer that, as these three groups primarily infect
different tissue types (mucosal epithelia for alpha; cutaneous for beta, gamma, lambda,
and xi; and fibroblasts for delta) that this in some way represents an element of the
adaptive radiation the virus underwent to adopt these infectious substrates. Still,
whatever the explanation for this observation, it should remind researchers to be
cautious when drawing generalizations between papillomavirus genera E2 proteins,
since a particular feature of BPV1 E2 protein may function differently or even be absent

for other PVs, as was eventually discovered to be the case with HPV16 and BPV1’s
respective utilization of Brd4 for chromosome replication(204).

Figure 2.1: Consensus Sequence Analysis of E2BSs Throughout Papillomavirus
Genera. Well characterized E2BSs from HPV16, 18, and BPV1 were analyzed using
MEME software to generate a consensus E2BS motif (Fig 2.1A.) This motif was then
utilized by MAST software to search through the complete genomes of 128
papillomaviruses obtained from NCBI and identify sequences with high identity to the
consensus. The average number of E2BSs identified per genome were sorted into the
six largest papillomavirus genera and were further analyzed to determine if the binding
sites were located within or without the upstream regulatory region (URR) of the genome
(Fig 2.1B.) Identified E2BSs were then manually analyzed to determine the GC content
of their four base spacer regions. Results were again calculated in terms of average GC
content of E2BSs for each of the individual papillomavirus genera both inside and
outside the URR as well as in total (Fig 2.1C.) Finally, the identified binding sites were
used for MEME analysis to identify the consensus E2BS motif for each of the six
papillomavirus genera analyzed in this study (Fig 2.1D.)
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Figure 2.2: Phylogenetic Analysis of Papillomavirus E2 Protein E2 protein amino
acid sequences for each of the papillomaviruses included in this study were obtained
from PDB and used for COBALT analysis. The resulting multiple alignment was then
used to generate a phylogenetic tree to analyze papillomavirus evolution in terms of the
E2 protein (Fig 2.2A.) Clades were identified corresponding to the classical PV genera
and indicated on the tree, as well as two subclades of the alphapapillomavirus genera.
These were then expanded and examined individually, and the locations of various types
of alphapapillomaviruses (specifically those capable of infecting cutaneous keratinocytes
and those possessing a high risk of progression to cervical cancer) were indicated (Fig
2.2B.) HPV E2BSs from part one were then reanalyzed using MEME software to identify
a consensus E2BS for the subclades identified in 2b, ie subclade 1 and 2, high and low
risk alphapapillomaviruses, as well as those capable of infecting cutaneous
keratinocytes tissue (Fig 2.2C.)
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Figure 2.3: E2 DNA Binding Domain Protein Alignment Amino acid sequence for all
known E2 proteins were acquired from NCBI and aligned using Muscle . (2.3A) This
figure shows the sequence alignment of the Alphapapillomavirus c-terminal DNA binding
domain of E2. Colors represent homologous amino acids. (2.3B) This figure shows the
sequence alignment of the Betapapillomavirus c-terminal DNA binding domain of E2.
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Figure 2.4: E2 DNA Binding Domain WebLogo Weblogo was used to generate a
graphical representation of the sequence analysis of the c-terminal DNA binding domain
of E2. The black box represents the conserved region where E2 protein binds to DNA in
the Alphapapillomavirus (2.4A) sequence similarity and the Betapapillomaviruses (2.4B).
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ABSTRACT
Human papillomaviruses (HPVs) replicate in mitotically active basal keratinocytes
as nuclear plasmids. Two virally encoded proteins, E1, a helicase, and E2, a
transcription factor, are important for DNA replication and stable maintenance of HPV
episomes in host cells. In previous studies, we have demonstrated that HPV16 can
replicate stably in yeast (Saccharomyces cerevisiae) (7, 158). In this study, we further
demonstrate that multiple HPVs (Types, 6, 16, and 31), when linked to the Ura3
nutritional marker, successfully replicate and are maintained extrachromasomally in
yeast. We found differences in replication efficiency; HPV6-Ura3 was the most robust
replicator, followed by HPV31-Ura3 and HPV16-Ura3 respectively, while HPV11-Ura3
and HPV18-Ura3 were unable to replicate in the absence of E2 expression. However,
we found no evidence that the BPV-Ura3 construct could replicate stably in yeast and
the addition of a yeast centromere provided only partial complementation. Together, our
studies indicate that there are intrinsic genotype-dependent differences in HPV
replication activity in yeast.

INTRODUCTION
Human papillomaviruses (HPVs) are small, double stranded, circular DNA
viruses that infect squamous epithelial cells. Two hundred species of HPVs have been
identified and are classified into low and high risk categories based on their association
with cervical oncogenesis. Integration of the viral genome into host chromosomes is
necessary for the development of cervical cancer (306).
The life cycles of papillomaviruses are closely associated to the their host cells.
During the course of epithelial cellular differentiation, the virus shifts through three
replication phases in response to keratinization: establishment, wherein early viral
replication occurs; maintenance, where the viral genome is stably maintained episomally
by replicating through a theta intermediate; and amplification, where viral replication
shifts to a rolling-circle method and copy number increases in preparation for
encapsidation (112). Papillomavirus DNA replication requires primarily cellular factors,
recruiting DNA polymerase alpha along with other elements of the cellular replication
machinery (240). The accepted model utilizes the viral proteins E1 and E2 for genomic
amplification (95, 250, 301).
The E1 protein functions as an ATP dependent helicase and recruits DNA
polymerase alpha to act as an elongation factor (117, 217, 242). E2 has multiple
functions, including acting as a transcriptional trans-activator, an origin recognition
protein, and facilitating binding of E1 to the E1 dependent origin (244). Additionally, E2
serves as a maintenance factor by improving inheritance through mechanisms that are
not entirely understood, but may be the result of E2 binding either to chromosomal DNA
or mitotic spindles (22, 71, 170, 273). Previous research has indicated that
papillomavirus genomes can be replicated and maintained stably in the absence of E1

and E2 (7, 158, 336). Silencing mutations of the individual HPV open reading frames
have shown that none of the individual ORFs are required for successful genomic DNA
replication and maintenance (7). Since it has been demonstrated that replication of
papillomavirus genomes occurs in the absence of viral proteins in yeast, it is apparent
then that cellular factors must replace E1 function. For instance, the E1 protein forms
hexamers which function in a similar manner to cellular helicases such as Werner’s
(WRN) and Bloom’s (BLM) Syndrome Helicases, members of the RecQ family, and the
minichromosome maintenance proteins (MCM) (102, 117, 216, 242). It is conceivable,
then, that host factors could be adapted to perform similar replication functions in place
of viral proteins like E1, suggesting that an E1-independent mode of replication could be
relevant during the maintenance phase of the HPV lifecycle.
Studies have previously indicated that HPV16 is capable of replicating in S.
cerevisiae in an E1 independent manner (7, 158, 159). Previous efforts by the Lambert
laboratory identified regions of the HPV16 genome which are responsible for this trans
factor independent replication, showing that portions of the L2 and L1 open reading
frames possess replication and maintenance function (158). Plasmids with these cisacting factors present were capable of long-term, stable, episomal replication
independent of viral replication factors.
Having initially established that HPV genomes can replicate in Saccaromyces
cerevisiae, the HPV/yeast system has proven easy to manipulate for the study of certain
aspects of the HPV lifecycle, including transcription, replication and production of viruslike-particles (VLPs). HPVs 6b, 11, 16, 18, and 31 replicate in short-term assays when
transformed into competent yeast (5-7, 158, 336, 337). Furthermore, the Frazier
laboratory has reported that BPV1 replicates robustly in yeast (336, 337). Recently the
Khan laboratory has reported that HPV1 can replicate in yeast, but requires a

centromere to be maintained stably (51). Kim et. al. mapped both ARS and CEN
replication functions in S. cerevisiae to the late region of HPV16(158). The great degree
of homology between the genomic replication mechanisms of yeast and higher
organisms creates the possibility that similar mechanisms could be involved in
papillomavirus replication in higher eukaryotes, especially during the maintenance phase
when expression of E1 and E2 is minimal.
In this study, we investigate the long term replicative and maintenance
competence of five HPV types: HPV6b, 11, 16, 18, and 31 along with BPV1. Replicons
containing a Ura3 nutritional marker were created for each papillomavirus, transformed
into yeast, and analyzed by Southern Blot to confirm that HPV6b, 16, and 31 genomes
were replicating episomally while HPV11 and 18 were not. Notably, BPV1, which had
previously been reported to replicate in yeast (336, 337), failed to show significant long
term growth in selective media even when complemented with the inclusion of a
centromere.

MATERIALS AND METHODS

Yeast Strains, Plasmid Isolation and Transformation Methods. The haploid yeast
strain YPH500 (MAT ura3-53 lys2-801 ade2-101 trp1-63 his3-200 leu2-1) was used for
all described experiments. Yeast was grown on YNB minimal media omitting uracil (Ura)
at 30 °C for all transformation and Southern experiments, while YPD complete media
was utilized additionally to examine plasmid stability and loss rate. The EZ Yeast
Transformation kit (Zymo Research, Orange, Calif.) was used for transformation with the
experimental plasmids according to the kit protocol and the Zymoprep kit (Zymo

Research, Orange, Calif.) was used for yeast plasmid minipreps according to company
specifications.
Plasmid Constructions Numerous constructs were created using similar methods. The
Ura3 gene was ligated into unique restriction sites in either the papillomavirus genome
or vector sequence, selected in E. coli grown on Luria Broth media containing Ampicilin,
and the DNAs were isolated using the Qiaprep Spin Miniprep Kit (Qiagen Sciences,
Maryland 20874) in accordance with the manufacturer’s instructions. The Ura3 markers
were cloned into the various constructs as follows: pPA102 (pGEMT, AgeI), pPA103
(HPV16, XhoI), pPA104 (Puc18, SalI), pPA106 (HPV31, SpeI), pPA112 (PPR 322 with
HPV18 ligated into Nco site, AVRII), pPA116 (HPV6, AgeI), pPA117 (HPV11, AgeI),
and pPA118 (BPV, Mlu I). Construct PA119 was created by digesting pΔYac with AvrII,
releasing the CEN element, and then ligating this fragment into a unique AvrII site in
pPA118. PRS 316, an ARS+ CEN+ Ura3+ yeast replicon, was included as a positive
control.
DNA Replication in Yeast Two-hundred ng of each plasmid was transformed into
YPH500 yeast, plated on Ura- selective agar, and incubated for 3 days at 30°C. Plates
were then scored for number of colonies formed and restreaked on selective solid agar,
grown for an additional 3 days, and inoculated into 5mL of Ura- liquid media and allowed
to grow for approximately 40-50 cell generations. OD600 was recorded for each sample
to obtain approximate number of cell equivalents per milliliter, and samples were diluted
in order to equalize this number, allowing for a determination of copy number by
Southern Blot. Low molecular weight DNA was isolated from liquid culture as described
above. The DNA was then loaded onto a 1% agarose gel, electrophoresed, transferred
to nitrocellulose, and probed with 32P-radiolabeled pPA104. Radiolabeling was

performed using the Amersham Rediprime II kit (GE Healthcare UK, Buckinghamshire)
in accordance with the manufacturer’s instructions.

Growth Curves 5 milliliters of liquid Ura- media were inoculated to an OD600 of 0.15 with
each of the papillomavirus genomes transformed into S. cerevisiae, as well as PRS316.
In addition, 5 mL of YPD media was inoculated to an equivalent OD600 with
untransformed YPH500 yeast to establish a standard doubling time. OD600 for each
sample was recorded at time points 0, 3, 6, 8, 24, and 30 hours after inoculation.
Growth rate was then determined by calculating doubling time during the mid log growth
phase using the formula Td=(tf-ti)*[log(2)/log(qf/qi)] where Td is doubling time, tf and ti are
time final and initial, and qf and qi are the OD600 values at the tf and ti.
Plasmid Loss Rate Assay The plasmid loss rate per cell generation was calculated
utilizing a method similar to that described by Marahahrens et. al. (196) Briefly,
approximately 100-200 cells were plated onto YPD and YNB-Ura plates after being
removed from selection at time points of 0, 4, and 8 hours post inoculation. All sets of
plates were then incubated for 3 days and scored for colony growth. Plasmid loss rate
was then calculated using the formula L=Pf-Pi/T where L is the percent loss rate per cell
generation, Pf is the percentage of growing yeast which contained the plasmid at the
final time point, Pi is the percentage of growing yeast with the plasmid at the initial time
point, and T is the number of cell generations.

RESULTS
Varying Replicative Efficiencies of Different HPVs in Yeast
In order to investigate the DNA replication capability of varying Papillomaviral
species in yeast, we generated plasmid constructs by cloning a Ura3 nutritional marker
along with the complete papillomaviral genomes into the multicloning site of Puc18
(Figure 3.1). These were then transfected into YPH500 yeast and observed for ability to
generate stable colonies that can be streaked onto new plates and grown in liquid
media.
Yeast transformed with the different HPV/Ura3 constructs demonstrated very
different growth characteristics when plated on selective media (Figure 3.2). Some, like
pPA112 and pPA117, showed very little growth on the plates, with at best only one to
two colonies growing (likely the result of recombination or integration of the Ura3 marker
into yeast genome). We had previously demonstrated HPV 16-Ura’s long term plasmid
maintenance in yeast (7), and confirmed that result here. pPA116 and pPA106
transformed yeast seemed to grow as well, or better than pPA103 on selective media.
Significantly, BPV1-Ura (pPA118) showed no colony growth on selective media.
Inclusion of a yeast centromere in an HPV1 plasmid construct had previously been
shown to allow for genomic maintenance (51). Cloning of a CEN element into pPA118
resulted in small, slow growing yeast colonies containing the plasmid (Figure 3.2) which
were difficult to further propagate.
Southern blotting was performed to confirm that the HPVs which replicated
successfully in yeast were being maintained episomally. As the HPV genomes have
varying sequences and restriction digest profiles, DNA was run uncut after collection by

yeast mini-prep and will appear on the gel to possess both the low molecular weight
supercoiled form along with a number of higher molecular weight nicked-supercoil forms.
Expected molecular weights for the products are as follows: PA116 (HPV6b-Ura3)
11,485 bases, PA103 (HPV16-Ura3) 11,395 , PA106 (HPV31-Ura3) 11,401 bases,
PRS316 (ARS+CEN+ control) 4887. HPV plasmids replicated at varying copy numbers
(Figure 3.3), with HPV6 and 31 appearing to be between 10 and 50 copies per cell while
HPV16 was maintained at 1-5 copies per cell, as compared to input standards.
Growth Rates and Plasmid Stability of HPV-Ura Constructs
Experiments with liquid media inoculations allowed for a closer examination of
the growth characteristics of each HPV genome transformed yeast culture. By
observing changes in OD600 over several hours, a doubling time for the mid-log phase of
each yeast culture was obtained (Figure 4). HPV6-Ura (pPA116) had the longest
doubling time, 7.5 hours, while pPA103 had the shortest at 3.3 hours. All three HPV
transformed yeast strains grew more slowly than untransformed YPH500 in YPD
complete media or PRS316 positive control transformed yeast.
Additionally, experiments were performed to determine and compare the rate at
which plasmid is lost from yeast once removed from selection. All four plasmids which
could replicate in yeast were grown first in selective media (-Ura) to mid-log phase and
diluted to an OD600 of 0.15 into new cultures containing nonselective media (+Ura). The
cultures were grown, and at fixed time points, an equivalent number of cells were plated
from each culture onto both selective and nonselective media plates, allowing for
determination of the ratio of yeast which had maintained the plasmid vs. yeast which had
lost it over their individual number of cell divisions. The results are shown in Table 1. All

three HPV constructs replicated with a high degree of stability similar to that of the ARS+
CEN+ positive control, PRS316.

DISCUSSION
Our results indicate that certain HPVs (6, 16 and 31) replicate stably in yeast,
while some do not (HPV 18 and 11). The definition of stable replication used in this
study is based primarily on the ability to form colonies on selective media which can be
restreaked and subcultured onto a new solid media plate as well as liquid media.
Previous studies performed by Angeletti et. al. as well as Frazer et. al. have previously
established that HPV 11, 18, and BPV1 are capable of replicating successfully in yeast
during short term assays utilizing complete, non-selective liquid media (2,24,25).
Growth on solid, selective media characteristically includes a 1-3 day growth period
wherein yeast colonies are either not visible or very small, resembling petite mutants.
Consequently, a replicon which does not replicate stably will not develop to the point of
seeing visible colonies and, thus, would be scored as not replicating stably.
The great degree of conservation between the DNA replication systems of yeast
and higher eukaryotes suggests the possibility that certain factors may be involved in
papillomavirus genome replication and maintenance for both systems. As stated
previously, papillomaviruses spend the majority of their life cycle in a maintenance
phase, replicating episomally at low copy number, with only minimal expression of the
virus’s replication factors E1 and E2. We have previously demonstrated that HPV16 is
capable of replicating with cis acting factors alone in the absence of E1 and E2 (7).
Also, Hoffman et. al. have previously demonstrated that HPV16 replicates in a once-perS-phase manner in certain cell lines, depending on the presence or absence of viral

replication factors, while HPV31 only replicates randomly under the study conditions
(147).
All of these results point to a large degree of reliance upon host factors for
regulation of viral genome replication and maintenance. The differences in replication
and/or maintenance success of different HPV types could represent genotypedependent differences in cis-acting elements in the late region of the genomes as
compared to that of HPV16, which was recently shown to provide both functions by Kim
et al. Completing similar mapping experiments of other HPV types should help identify
which cis acting factors are playing a role in yeast replicative success, but also if the
trend for late region replication and maintenance functions observed by Kim, holds true
for other HPVs. In addition, the experiments described by Hoffman et al., if performed in
yeast, should shed light on the mode of replication being utilized. Furthermore, while all
the HPVs in this study replicate successfully in host cells, the difference in replicative
success shown in this study may imply a greater or lesser degree of utilization of host
replication factors between varying HPV types and differing dependence on E1 and/or
E2.
Notably, there seemed to be some degree of difference when comparing the
Southern Blot versus the liquid culture growth curves. Specifically HPV16 appeared to
have a reduced copy number compared to the other HPV replicons but demonstrated a
similar growth rate in transformed yeast. Presumably an increased copy number would
lead to increased transcription of the Ura3 nutritional marker and, thus, more growth.
The reason for this discrepancy is not currently apparent, but one potential explanation
could be an underestimation of HPV16’s copy number by the assay. In any case,
differences between the growth rates of the HPV replicons as compared to controls were
not appreciably different.

Contrary to reports that BPV could replicate in yeast (336), we found that BPVUra was unstable during long-term replication. In short-term yeast experiments, we
previously showed that BPV could generate Dpn I resistant DNA products, indicating
that replication is initiated but that DNAs are most likely not stably maintained (7).
However, the addition of a centromere region (pPA119 plasmid), resulted in only partial
complementation of maintenance function. This result may be related to the much
greater number of E2 binding sites contained within the BPV genome (17 for BPV, as
compared to 4 E2BS for HPV16) (177), implying perhaps a greater reliance on E2
tethering. Despite our careful analysis, BPV1 does not appear to be stably maintained in
yeast. It is possible that this is the result of differences between the mammalian Brd4
protein and its yeast homologue, Bdf1, which lacks the C-terminal domain that has been
shown to interact with E2. Fusion proteins of Bdf1 and the C-terminus of Brd4 restores
E2 maintenance function (41), and it is likely that a similar effect would be observed
here.

FIGURE 3.1. Plasmid Maps. Into each HPV genome, a Ura3 gene cassette was
introduced as shown in each of the plasmid maps. The pPA103 vector contains the
HPV16 genome with the Ura gene inserted at nt 7309 of the genome, as indicated.
PPA106 contains the HPV31 genome, pPA112 contains the HPV18 genome, pPA116
contains the HPV6 genome, pPA117 contains the HPV11 genome, pPA118 contains the
BPV genome, and pPA119 contains the BPV genome with a yeast centromere inserted.
Control plasmids included pPA104 (puc-Ura3), pGemT-Ura3 as negative controls and
pRS316, as a positive control.
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Figure 3.2. Yeast Transformations Two-hundred ng of each plasmid construct was
transformed into YPH500 yeast, plated onto YNB –Ura media, and allowed to grow for
72 hours. Plates were then scanned and scored for growth.
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Figure 3.3. Southern Blot All successfully replicating constructs (HPV6 Ura, HPV16
Ura, HPV31 Ura, and PRS316) were inoculated into 5mL of YNB-Ura media and
incubated for 2 days. Small molecular weight DNA was then harvested via yeast
miniprep, loaded into 1% agarose gel, and electrophoresed. DNA was then transferred
to a nitrocellulose membrane and analyzed via Southern Blot pPA116 (HPV6 Ura),
pPA103 (HPV16 Ura), pPA106 (HPV31 Ura), and pPRS 316 were probed utilizing P32
radiolabelled Ura-3. . Control volumes of HPV6 Ura were utilized in the first 3 lanes to
provide an idea of relative copy number. Plasmids are run uncut and circular and, as
such, will show the predicted lower molecular weight supercoiled form as well as 1-3
nicked supercoil forms which will appear to possess a greater molecular weight.
Expected molecular weights are as follows: PA116 (HPV6b-Ura3) 11,485 bases, PA103
(HPV16-Ura3) 11,395 , PA106 (HPV31-Ura3) 11,401 bases, PRS316 (ARS+CEN+
control) 4887. Arrows indicate the supercoiled form visible on the gel.
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Figure 3.4A) Plasmid Construct Master Plate After initial growth upon being
transformed into yeast, colonies were restreaked onto an additional –Ura plate both to
provide for ease of manipulation and also to examine long term maintenance. All
plasmids which grew initially continued to grow stably on the master plate. Additionally,
BPV-CEN showed signs of limited growth, evident as small colonies. 3.4B) Growth
Curve 5 mL of liquid media was inoculated to an OD600 of .15 with each of the
successfully replicating plasmid constructs (HPV6, 16, and 31 Ura as well as p RS316.)
Additionally, a similar OD600 was generated with YPH500 alone grown in YPD complete
media. OD600 was recorded at time points 0, 3, 6, 8, 24, and 30 hours post inoculation.
Growth rate was then determined by calculating doubling time during the mid log growth
phase
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Table 3.1. Plasmid Loss Rate Yeast transformed with the successfully replicating
plasmid constructs were inoculated into YPD complete media. Approximately 100-200
cells were the plated onto YPD and YNB-Ura plates after being removed from selection
at time points of 0, 4, and 8 hours post inoculation. All sets of plates were then
incubated for 3 days and scored for colony growth. Plasmid loss rate was then
calculated using the formula L=Pf-Pi/T where L is the percent loss rate per cell
generation, Pf is the percentage of growing yeast which contained the plasmid at the
final time point, Pi is the percentage of growing yeast with the plasmid at the initial time
point, and T is the number of cell generations.

Table 3.1

Construct

Percent Loss
Per CG

pPA116 (HPV6)

2.63

pPA103 (HPV16)

0.64

pPA106 (HPV31)

2.40

pRS316

1.56

Chapter 4
Interaction of TRF2 with HPV16 E2 and Shelterin’s Role in HPV16 Plasmid
Stability

A Role for Telomere-related Factors in HPV DNA Maintenance
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*Author’s Note: Work for figures 2, 3, and 6 was completed by Daraporn
Pittayakhajonwut and are included here for completeness.

ABSTRACT
Papillomaviruses (PV) are small non-enveloped viruses which contain a
single molecule of circular supercoiled double stranded DNA (339). The accepted
replication model relies on the viral proteins E1 and E2 for genomic amplification (95,
250, 301). Previous research, however, has indicated that papillomavirus genomes can
be replicated and maintained stably in the absence of E1 and E2 (7, 158, 336). The
observations suggest the maintenance phase of the HPV life cycle may be adapted to
extremely low or no E1 and E2.
HPV genomes can persist as episomes in infected individuals for years, which
contribute to the development of cancers. Bovine papillomavirus (BPV) E2 tethers newly
synthesized genomes to mitotic chromosomes to ensure faithful partitioning of genomes
to daughter cells. However, further study demonstrated that, while all papillomavirus E2
proteins studied thus far utilize Brd4 for transcriptional purposes, it is dispensable for
plasmid maintenance in HPVs (206). The mechanism of E2-dependent maintenance
function thus remains somewhat cryptic. Although binding of E2 to Mitotic Chromosomes
is consistently observed, the binding location is not conserved amongst HPV types
(231). A recent study suggests that E1 is required for localization of HPV16E2 and viral
DNA to fragile sites on Mitotic Chromosomes (255).
HPV16 possesses an E2-independent cis-acting maintenance function mapped
to the L2 and L1 ORFs (nt 4538-7013)(245). Interestingly, the late region (L2, L1, and
the LCR) of HPV16 contains four nine-base DNA sequences corresponding to binding
sites for telomere maintenance proteins like TRF2. Further analysis of several HPV
genomes revealed that TRF binding sites are relatively common in HPV genomes and
are usually found within the late region. Site-directed mutagenesis of these sites in
HPV16 resulted in increased plasmid instability, copy number changes, and in some

cases complete loss of plasmid maintenance in human and yeast cell models. Further
studies revealed that telomeric protein levels are altered in HPV16 harboring cells, and
chromatin immunoprecipitation (ChIP) results indicating TRF2 and other telomererelated proteins such as POT1, TIN2 and BLM helicase are able to bind these telomeric
nonamer sequences. Additionally, it was demonstrated that HPV16 E2 protein interacts
with the TRF2 scaffold protein, along with a number of other shelterin components.
Furthermore, mutating these telomere binding sites to prevent protein binding induced a
moderately destabilizing effect on papillomavirus replication in yeast. Long-term
replication assays using a plasmid containing an OriP dyad symmetry element and a
series of mutants lacking TRF binding sites also induced plasmid instability in
transfected mammalian cells, albeit to a lesser extent than that observed in yeast. Since
tight regulation of copy number is an important part of the HPV lifecycle, it can be
concluded that TRF proteins play an important role in establishing successful DNA
maintenance of HPV.

INTRODUCTION
Papillomaviruses (PV) are small (55nm diameter) non-enveloped viruses of
icosahedral capsid symmetry that encapsidate a circular supercoiled double stranded
DNA genome (339). This family of viruses infects the stratified epithelia of the skin or
mucosal surfaces, which include the mouth, airways, and anogenital tissues of
vertebrate animals (75). Mucosal HPVs can be further classified into high-risk and lowrisk, with the former being the causative agents of cervical cancer as well as some
vaginal, anal, and penile cancers (37, 57, 220), typically as a result of genomic
integration and resultant overexpression of the viral E6 and E7 oncogenes(306).
Mechanisms ensuring the high-fidelity replication and efficient segregation of the
newly replicated viral DNA to the dividing cells are key features of successful
persistence of HPV infection. Papillomavirus replication requires recruitment of cellular
factors, including DNA polymerase-α along with other elements of the cellular replication
machinery (240). The established model relies on the viral proteins E1 and E2 for
genomic amplification (95, 250, 301). E1 unwinds the viral genome through its ATPdependant helicase activity. E1 is loaded onto the origin by the E2 protein, which is
colocalized at the HPV replication foci with the L2 protein (76). Previous studies,
however, have indicated that papillomavirus genomes can be replicated and maintained
stably in the absence of E1 and E2 (7, 158, 336)
An analogy for the possible strategy of stable HPV DNA maintenance comes
from similar mechanisms observed in other DNA tumor viruses, such as Epstein-Barr
virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV) that initiate similar
latency stages during their life cycles (19, 21, 140, 188, 272, 324). “Hitchhiking” by

tethering viral genomes to chromosomal DNA by use of a virally encoded protein as a
tethering molecule to allow partitioning and nuclear retention of the viral genomes during
mitosis is the common feature among these persistent viruses (38, 110). A single viral
protein acts as a molecular linker that establishes a bridge between the viral genome
and host mitotic chromosomes. The viral transactivator Epstein Barr Virus Nuclear
Antigen 1 (EBNA1) and transcriptional repressor Latency Associated Nuclear Antigen
(LANA-1) function as the bridge molecules for the hitchhiking strategy thought to be
used by EBV (179) and KSHV (18, 19), respectively.
In the case of papillomaviruses, a similar mode of viral DNA maintenance has
been characterized, mainly based on studies related to chromosomal segregation in
bovine papillomavirus type 1 (BPV1). E2 polypeptides contain three probable domains:
a DNA binding domain (DBD) located at the C-terminus, an N-terminus transactivation
domain, and an internal “hinge” domain. Both the C-terminal and N-terminal domains are
well conserved within the PVs (254). E2 protein mediates genome maintenance by
interaction of its transactivation domain with mitotic chromosomes while the DNA binding
domain tethers genomes through the association with multiple E2 binding sites. Further
studies have identified that Brd4, a cellular bromodomain protein, is a major component
of the tethering complex that attaches the viral genomes to host mitotic chromosomes
(25, 200, 207, 329). Both the BPV1 E2 protein and viral genomes colocalize with Brd4
on mitotic chromosomes in punctate spots with no specific attachment sites identified
(274). Disruption of the E2-Brd4 interaction dissociates E2 from chromosomes and
abolishes viral genome maintenance (200).
Although this interaction is the mechanism of DNA maintenance for BPV1, the
interaction between E2 and Brd4 is required for E2-mediated transcriptional regulation
but not for genome tethering of other PV subtypes (205, 263, 318). Further analysis has

demonstrated that E2 mutants lacking Brd4 binding remained attached to mitotic
chromosomes (230). Therefore, different PVs might utilize different cellular proteins or
alternate strategies to maintain the viral genome in the host cells.
In a previous study, our laboratory has mapped maintenance elements that
provide plasmid stability in two distinct regions in HPV16 genome (245). These HPV16
subgenomic fragments are located outside of the LCR that contains multiple E2 binding
sites (E2BS) and they function as maintenance elements in the absence of any viral
protein(245). This finding is consistent with a separate study in yeast in which
subgenomic fragments of HPV DNA can autonomously replicate and persist in the
absence of E1 and E2 proteins (7, 158). Together, these studies led to the hypothesis
that the interaction of viral cis-elements with cellular factors may influence viral DNA
maintenance. Sequence analysis identified several possible cellular candidates that can
bind to the viral genome and contribute to HPV DNA maintenance. Of those potential
candidates, four nine-base DNA sequences of telomeric DNA (TTAGGGTTA) are found
within the viral genome, three of which are located in the cis-element that is part of the
previously identified maintenance element (Figure 1A). TRF binding sites are prevalent
among many HPV genomes, whereas there are none in BPV1 (Figure 1B).
Plasmids which contain the Epstein Barr Virus latent origin (OriP) utilize a similar
TRF binding site system for long-term plasmid replication and stability. The dyad
symmetry region (DS contains 4 sites of nine-base telomeric repeat DNA in the DS
region, similar to those found in the late region of HPV. These repeats are required for
DNA replication (225) and plasmid maintenance (225, 325). These telomeric repeats
allow binding of TRF2 by DNA affinity assay (87), which is required for plasmid
replication and maintenance (87, 323). One important function of TRF2’s role in OriP
replication is recruiting the proteins of the Origin Recognition Complex (ORC). TRF2

interacts with EBNA1 (169), a structural and functional homologue of the HPV E2
protein, and this interaction is required for the replication and maintenance effect (85,
87). These processes are inhibited by overexpression of a TRF2 dominant negative
plasmid with the N and C terminal domains deleted (85).
Kaposi’s Sarcoma Herpesvirus (KSHV) also encodes a structural and functional
homologue of the HPV E2 and EBV EBNA1 protiens, Latency Associated Nuclear
Antigen (LANA.) LANA is responsible for latent phase DNA replication, gene expression,
and segregation, again similar to the E2 and EBNA1 proteins (20). A study performed
by the Renne laboratory demonstrated that, along with thirty other proteins, TRF2
associates with a seventy base pair minimal replication element from the KSHV genome
(149). LANA co-immunoprecipitates with TRF2, but interestingly only when
cotransfected with a plasmid containing an intact, wild type copy of the viral tandemrepeates (TR). These observations encouraged the hypothesis that the TRF binding
sites in cis and TRF proteins in trans contribute to episomal maintenance of HPV
genome.
The telomere is maintained through the action of a number of proteins combining
together into a protein complex called shelterin. The shelterin/telosome complex
functions primarily by bringing the three telomeric DNA binding factors (TRF1, TRF2 and
Pot1) into the same large complex (78, 181, 237) along with Ras related protein 1
(RAP1) (173), and TRF1-Interacting Protein (TIN2) (77). TRF1 and 2 (telomeric repeat
factors 1 and 2) bind duplex telomeric DNA (43), almost entirely associated with cellular
chromatin (288). TRF1 and 2 share a common architecture defined by two conserved
regions: a TRFH domain that mediates homodimerization and a carboxy-terminal DNA
binding domain of the SANT/Myb family (43). TRF2 promotes development of T-loop
structures (134, 283), potentially as a result of positive supercoiling (4). TRF2 also

serves to stabilize T-loops (116) through their N-terminal domain’s ability to bind ss-DNA
in a number of secondary structures. TRF2 also interacts extensively with members of
the cellular DNA repair system including Ataxia Telangiectasia Mutated (ATM) and the
MRE11 recombination-repair complex(40, 80). TRF2 and POT1 proteins physically bind
to the RecQ helicase, Werner syndrome ATP-Dependent Helicase (WRN), and then
stimulate the helicase activity to unwind duplex telomeric substrate (127). The precise
roles of RecQ helicase in telomere maintenance are unclear, however, they likely to
function in recombination and/or replication of telomeric ends. TRF2 plays a duel role in
DNA repair, inhibiting the action of repair proteins acting on the ends of chromosomes
while, at the same time, being phosphorylated by ATM and relocating to sites of DNA
breaks to improve homology based recombination repair(275).
In this work, Chromatin Immunoprecipitation (ChIP) assays were used to
examine the interaction of TRF2 and its related proteins with the predicted TRF binding
site in HPV16 DNA. We also investigated the role of the suspected TRF binding sites
and the associated proteins in viral DNA maintenance. It appeared that telomere-related
proteins such as TRF2, POT1, TIN2, and Bloom Syndrome Protein (BLM), a RecQ
helicase similar to WRN, can bind to the HPV16 genome at the TRF binding site and
these interactions contribute to the regulation of the viral genome copy number. Through
both bacterial and mammalian expressed proteins, we demonstrated that TRF2
interracts with HPV16 E2, and furthermore that E2 interacts with other shelterin complex
proteins. We utilized immunofluorescence to show that E2 interacts with TRF2 in cells
outside of E1E2 replication foci. Through site-directed mutagenesis, we demonstrated a
copy-number effect was induced when TRF2 binding sites were removed from
previously stable plasmids replicating in both yeast and mammalian cells. These results
lead us to suggest that TRF2 plays an important role in HPV16 plasmid stability.

MATERIALS AND METHODS
Plasmid Constructs Several yeast constructs were created using similar methods.
The negative control plasmid, pPA104 (ARS-, CEN-), was created by cloning the Ura3
gene into the Sal I restriction site of pPuc19. The original HPV16-Ura3 containing
plasmid, pPA103 was described in Angeletti et al. (2002) (158). The pPA111 plasmid
contains an ARS+ CEN- backbone and a Trp marker which also has the L2 fragment (nt
4538-5072) of HPV16 shown to have maintenance function (described as pPA94;mtc2
library isolate in the original publication) (158). The pPA113 plasmid (pyac CEN- L1; nt
6150-6950) was originally described as the pPA94:mtc3 library isolate. pPA103-2 was
constructed by performing restriction digest with Spe1 to Brs 361 in order to remove the
early region and most of the long control region from PA103 (nucleotides 1462-4337),
leaving the late region to the LCR intact (4338-56).
The predicted TRF binding sites were designated A, B, and C by the order of
their distributions in HPV16 genome. pPA111 (Mtc2), containing the HPV16 L2 ORF,
had the TRF site identified as TRF A. pPA113 (Mtc3), containing the L1 ORF, contained
the TRF B and TRF C sites. pPA103-2 was further subjected to site-directed
mutagenesis to ablate TRF B and C binding sites.
Plasmid 2380 contains wild-type EBV OriP cloned in pPUR and was a generous
gift from Dr. Paul Lambert (University of Wisconsin-Madison). Plasmid 2380.1 was
constructed as a derivative of 2380, by inserting the AflIII fragment from pEGFP C1 that
contains the expression cassette of enhanced green fluorescent protein (EGFP) gene
into the EcoRI site of 2380. The AflIII fragment insert and the EcoRI cut 2380 plasmid
were blunt-ended by treatment with DNA polymerase I (klenow) prior to ligation.

Expression of EGFP is driven under the control of the cytomegalovirus (CMV) promoter.
Plasmid 2380.2 has a 914 bp deletion between MluI and XhoI from the plasmid 2380.1,
resulting in the removal of the family of repeat (FR). A subgenomic fragment of the
HPV16 late region containing 3 predicted TRF binding sites (A-C) was then inserted in
place of the FR to generate the 2380.5 plasmid. Those individual fragments were
cloned into 2380.2 using multiple linkers indicated in Table 4.1 to accommodate
incompatible ends at the insertion sites.
To generate TRF mutants, the L1L2GFP construct containing the HPV16 late
region that harbors three predicted TRF binding sites was modified by site-directed
mutagenesis (Stratagene Quickchange Kit, Stratagene) with 6 bp substitutions
converting the site(s) to the MluI restriction site. Initially, sites A, B, and C in plasmid
2380.5 were individually altered to make TRF mutation mutants, referred to as
2380.5A, 2380.5B and 2380.5C. These single-site mutants were then further
mutated to obtain double- and triple-binding-site mutation mutants. Constructs with two
TRF binding sites changed to MluI were named as 2380.5AB, 2380.5AC, and
2380.5BC, according to the sites which were modified. The triple-binding site mutation
mutant was denoted as 2380.5ABC.
The E2-His construct was created by cloning the HPV16 E2 ORF into the BamHindIII sites of pQE-9 6xHis tag vector and was a generous gift from the laboratory of
Lawrence Banks (ICGEB, Trieste Italy). Expression constructs of TRF1, TRF2, Rap1,
Tin2, and Pot1 as well as the GST expression empty vector were gifts from Dr. Paul
Lieberman’s laboratory and were created by PCR amplification of the gene and cloning
into pGEX-2T vector (340).

The E2-Flag was generated by cloning the HPV16 genome into the pCMV-Tag2
vector between the BamH1 and EcoR1 restriction sites.
Yeast Strains The haploid yeast strain YPH500 (MATα ura3-52 lys2-801_amber ade2101_ochre trp1-Δ63) was used for all described experiments. Yeast was grown on YNB
minimal media omitting uracil (Ura) at 30 °C for all transformation and Southern
experiments, while YPD complete media was utilized additionally to examine plasmid
stability and loss rate. The EZ Yeast Transformation kit (Zymo Research, Orange,
Calif.) was used for transformation with the experimental plasmids according to the kit
protocol and the Zymoprep kit (Zymo Research, Orange, Calif.) was used for yeast
plasmid minipreps according to manufacturer specifications.

Yeast Plasmid DNA Replication Assay Two-hundred ng of each plasmid was
transformed into YPH500 yeast, plated on Ura- selective agar, and incubated for 3 days
at 30°C. Plates were then scored for number of colonies formed and restreaked on
selective solid agar, grown for an additional 3 days, and inoculated into 5mL of Uraliquid media and allowed to grow for approximately 40-50 cell generations. OD600 was
recorded for each sample to obtain approximate number of cell equivalents per milliliter,
and samples were diluted in order to equalize the number of cells, thus allowing an
accurate determination of copy number by Southern Blot. Low molecular weight DNA
was isolated from liquid culture as described above. The DNA was then loaded onto a
1% agarose gel, electrophoresed, transferred to nitrocellulose, and probed with 32Pradiolabeled pPA104. Radiolabeling was performed using the Amersham Rediprime II
kit (GE Healthcare UK, Buckinghamshire) in accordance with the manufacturer’s
instructions.

Mammalian Cell culture and transfection methods Human embryonic kidney 293
cells and two genetic variants stably expressing Epstein Barr nuclear antigen 1, EBNA1,
(293E) or the large-T antigen (293T), fibroblast cell line NIH3T3, cervical cancer cell line
HeLa, and spontaneously transformed human keratinocyte HaCaT cells were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, USA) supplemented with 10%
heat-inactivated fetal bovine serum (FBS, Atlas, USA) and 1 mM sodium pyruvate.
Primary cells, neonatal human foreskin keratinocyte (NHFK), human foreskin
keratinocyte (HFK) and their derivative cells, HPV16 transformed NHFK (HPV16NHFK)
and hTERT-immortalized HFK (hTERT-HFK) were maintained in Keratinocyte Growth
Medium-2, KGM-2, supplemented with KGM-2 Bullet Kit (Lonza, USA) and 0.075 mM
calcium chloride. All cells were cultured at 37C in a fully humidified atmosphere of
5%CO2.
Primary keratinocytes were transfected using Primefect (Lonza, USA). Other cell
lines were transfected with Dreamfect Gold according to the manufacturer’s protocol.
Briefly, cells were plated the day before transfecting at density of 4 x 105 per 60 mm dish
or 2 x 106 per 100 mm dish. Cells were exposed to 2 g (60 mm dish) or 5 g (100 mm
dish) of DNA in DMEM containing a ratio of 4:1 Dreamfect (l):DNA (g) or 10:1
Primefect (l):DNA (g).
Nuclear extracts Nuclear extracts were prepared at 4C by extraction of nuclei with
high salt buffer by the following method. Briefly, cells were lysed with NP40 lysis buffer
(50 mM NaCl, 10 mM HEPES pH 8.0, 500 mM Sucrose, 1 mM EDTA and 0.5% NP40).
Cell nuclei were washed afterward with low salt buffer containing 50 mM NaCl and then
extracted with high salt buffer (350 mM NaCl, 10 mM HEPES pH 8.0, 25% glycerol, 0.1

mM EDTA). All buffers were freshly added with 7 mM mercaptoethanol and 1X protease
inhibitor cocktail III (Calbiochem) before used.
Nuclear pellet was proceeded with further purification step by sonication in
nuclear pallet solubilization (NPS) buffer (10 mM Tris-HCl, pH 8.0, 140 mM NaCl, 1 mM
dithiothreitol (DTT), protease inhibitor cocktail III, 1% Triton X-100, 0.1%
NaDeoxycholate). Soluble nuclear pellet fraction was collected after centrifugation at
18000 rpm for 30 min. Typically, 1 x 107 yielded 100 μl of nuclear extract with 7 mg of
protein per ml and 10 μl of soluble nuclear pallet fraction with 10 mg of protein per ml
according to the Micro BCA Protein assay kit (Pierce).
In vitro chromatin immunoprecipitation assay (ChIP) One μg of DNA was packed
with chromatin by Chromatin Assembly Kit (Active motif) prior to subjection to chromatin
immunoprecipiation (ChIP). The ChIP assay was conducted in vitro as described (295)
with the following modifications. Briefly, 500 ng of chromatinized pEF399 or the
L1L2Sph fragment was incubated with a mixture of 100 μl of nuclear extract and 100 μl
of soluble nuclear pellet fraction at 30C for 30 min. After the incubation, CaCl2 was
added to a final concentration of 3 mM. The sample was digested with 5 units of
micrococcal nuclease (MNase) (USB, Affymetrix) at room temperature for 15 min before
the reaction was terminated by adding a premixed solution containing 50 mM EDTA and
1% Sarkosyl. Formaldehyde was subsequently added for cross-linking and the reaction
was allowed to proceed for another 10 min. Then, glycine was added to a final
concentration of 0.125 M and the mixture was left on ice for 5 min to stop the crosslinking activity. The reaction was diluted 1:10 with ChIP dilution buffer (16.7 mM TrisHCl, pH8.0, 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X-100, 0.01% SDS). A 1/10
volume aliquot was taken as input control and the remaining solution was precleared
with Dynabeads protein G (Invitrogen) which was preblocked with 0.5 mg/ml sonicated

bacterial DNA and 1 mg/ml BSA. After 1 h incubation at 4C, the precleared supernatant
was then equally divided and incubated separately in the presence or in the absence of
antibodies at 4C overnight with rotation. Preblocked Dynabeads protein G were then
added and the mixture was incubated at 4C for 1 h to pull down immunoprecipitate
complexes. The beads were washed stepwise once each with the following buffers; low
salt immune complex wash buffer (20 mM Tris-HCl, pH 8.1, 150 mM NaCl, 2 mM EDTA,
1% Triton X-100, 0.1% SDS); high salt immune complex wash buffer (20 mM Tris-HCl,
pH 8.1, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS); LiCl immune complex
wash buffer (10 mM Tris-HCl, pH 8.1, 0.25 mM LiCl, 1 mM EDTA, 1% deoxycholic acid,
1% IGEPAL-CA630) and TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA). The DNAprotein complexes were then eluted twice with 250 μl of elution buffer (0.1 M NaHCO3,
1% SDS). Twenty μl of 5 M NaCl were added to input control and the eluted
supernatant containing immunoprecipitate complexes and incubated at 65C overnight
to reverse cross-linking. Immunoprecipitated DNA was then purified with
phenol:chloroform:isoamyl alcohol (25:24:1), chloroform:isoamyl alcohol (24:1) and
precipitated with isopropanol at room temperature for 20 min. After precipitation, DNA
was washed once with 70% ethanol, vacuum dried and resuspended in 20 μl of water.
The concentration of DNA was measured using nanodrop spectrometer at 260 nm. PCR
was performed with primers (Table 1) to individually amplify each predicted TRF binding
site. The PCR products were resolved on a 1.5% agarose gel and visualized after
ethidium bromide staining. The sizes of PCR products amplified by different pair of
primers were indicated in Table 4.1.
Mammalian Cell Long-term Replication Assays Approximately 4 x 105 293E cells
were transfected with 2 μg of plamids using Dreamfect Gold reagent in medium
containing 2% FBS. The media was changed at 4 h posttranfection. On the next day,

the transfected cells were cultured in the presence of 1 μg/ml of puromycin for 4 days to
favor the growth of cells containing the plasmids that are resistant to puromycin and
select out untransfected cells. After selection, cells were grown for another 14 days.
During the experimental period, cells were maintained and passaged in media
containing 250 μg/ml G418 to sustain the expression of EBNA1 protein for replication of
the plasmids harboring DS sequences. Equal amount of DNA isolated by Hirt extraction
at days 0 and 14 after removal of puromycin was subjected to Southern blotting using
EGFP as a probe. PhosphorImager analysis was used to quantify plasmid recovery.
The quantity of plasmids was converted to copy number by computing with respect to
copy number controls that were loaded alongside.
Western blotting Primary antibodies to TRF1 (GeneTex), TRF2 (GeneTex, Santa
Cruz), POT1 (Abcam), hRap1 (Lifespan Bioscience), hTERT (Santa Cruz
Biotechnology), Tin2 (Santa Cruz Biotechnology), TPP1 (R & D Systems), WRN (Novus
Biologicals), BLM (Santa Cruz Biotechnology), histone H3 (Cell Signaling Technology),
Flag (Sigma, Santa Cruz), 6xHis (Pierce), and GST (Pierce), were purchased and used
according to manufacturer’s protocols. Basically, 30 μg nuclear extract were separated
through 10% SDS-PAGE gels. Proteins were transferred to Immobilon-P membrane
(Millipore). The membrane was blocked for 1 h with Tris-buffered saline/Tween (0.02 M
Tris-HCl, pH 7.6, 0.136 M NaCl, 0.1% Tween 20) (TBS-T) containing 5% nonfat dry milk
and incubated with primary antibody at 4C overnight. Primary antibodies were diluted
1:1,000 or 1:2,000 in the blocking solution (TBS-T plus 5% dry milk). Blots were washed
three times for 10 min each with TBS-T, incubated with appropriate secondary antibody
conjugated with horseradish peroxidase, developed with Amersham ECL reagents and
then exposed to X-ray films.

FarWestern blots DH5α bacteria were transformed with His-tagged E2 and GST-tagged
telomere maintenance protein expression constructs and grown to an OD600 of .6-.8 in
100mL of LB media with Ampicillin. Protein expression was induced by addition of 1mM
IPTG for 1 hour. Cells were then spun down and collected in Sodium Chloride-TrisEDTA (STE)/lysozyme buffer and incubated on ice for 15 minutes prior to addition of
protease inhibitor cocktail and N-Lauroylsarcosine and sonicated on ice until lysate
became clear. Cell debris was spun out in a centrifuge at 4°C.
Protein extracts containing His-E2 were run on a 7% polyacrylamide gel and
transferred to nitrocellulose membrane as-per standard Western Blotting procedure.
Membranes were then probed with either a primary anti-E2 antibody or a solution
containing a GST-tagged telomere maintenance/repair protein (TRF1, TRF2, Pot1, as
well as GST alone and L2-GST as negative and positive controls) in 5% milk with
proteinase inhibitors. These were incubated at 4°C overnight, washed three times in
TBS-T, then probed with anti-GST antibody as-per standard Western Blotting protocol.
GST-His Pulldown Bacterial protein extracts were generated in a similar manner to Far
Western blot. E2-His protein extracts were then exposed to Ni-NTA beads and tumbled
at room temperature for 1 hour to bind His tagged protein. Beads were washed with PBS
three times before being added to bacterial protein extracts containing GST-tagged
telomere maintenance proteins. The slurries were incubated for an additional hour at
room temperature before beads were collected by centrifugation and washed repeatedly
with PBS until wash eluates contained the same amount of protein as background when
read using a Nanodrop ND-1000 Spectrophotometer device. Protein was then eluted
from the beads by boiling in 1x Laemli buffer and analyzed by western blot. Westerns
were probed with anti-GST antibody.

Co-Immunoprecipitation Assay Either 293 or NIH3T3 cells were transfected with E2Flag or Flag empty vector. Cells were incubated for either 2 days with 293 cells or 4
days with NIH3T3 cells prior to collection of protein lysate with lysis buffer (150mM NaCl,
10% NP-40, 50mM Tris pH8.0). Either Santa Cruz anti-TRF2 antibody produced in goat
or Invitrogen anti-Flag antibody produced in rabbit were coupled to Dynabeads Protien
G. Collected protein lysates were pre-cleared with Dynabeads bound with anti-goat or
anti-rabbit antibody and then incubated with the cells and then incubated with antibodybead complexes for 1 hour prior to pull-down. Proteins were directly eluted into Laemmli
buffer and analyzed by Western Blot as previously described.
Cellular Colocalization Assay 293 cells were plated into 6 well plates with sterile 1 dot
cover slips placed in the bottom of the wells. 24 hours later they were transfected with
plasmid as per previous protocol and allowed to grow for an additional 24 hours to
ensure proper gene expression. Cover slips were then removed, washed in PBS-T, fixed
in 4% paraformaldehyde, washed, permeabilized with .05% Triton-X 100, washed, and
blocked with 3% BSA. Once the cells were blocked, cover slips were placed in a
humidification chamber and incubated for 1 hour with anti-Flag antibody and anti-TRF2
antibody in PBS-T with 1%BSA. After another wash, secondary Alexa fluorochromes for
anti-Mouse Alexa 488 and anti-Rabbit Alexa 633 Far Red for 1 hour. Cells were finally
washed in 1:5000 dilluted Dapi stain in PBS-T, washed again, and then mounted with
Electron Microscopy Sciences Fluorogel with Tris Base. Slides were visualized using a
Confocal Laser Scanning microscope with Fluoview 500 confocal system on an Olympus
IX81 Inverted Scope. Images came from a 60x Oil Immersion lens and visualized with
wavelengths of 405, 488, and 633 nm.

RESULTS
Expression profile of telomeric DNA binding proteins and related proteins in various
cells
hTERT is up-regulated by the E6 protein in high risk HPV infected cells (26).
Subsequent elevated expression of hTERT in these cells imparts a tumorigenic
phenotype, presumably through the maintenance of telomere length. The regulation of
telomere integrity involves proteins associated with the telomeric repeat unit
(TTAGGGTTA) at the chromosome ends. However, expression levels of telomererelated proteins within the context of HPV infection have not been examined.
Therefore, expression levels of telomere binding proteins and associated
partners in keratinocytes that were harboring the HPV16 genome or that were
transformed by the hTERT gene were compared to parental normal cells. The HPV16
harboring keratinocytes were established by transfection of primary foreskin
keratinocytes, NHFK, with the linearized HPV16 genome. The transfected cells that
went through crisis (more than 30 passages) and became immortal were selected and
referred to as HPV16 immortalized cells (HPV16-NHFK), with HPV16 presence
confirmed by Southern Blot. The hTERT-immortalized keratinocytes were a gift from Dr.
Al Klingelhutz and are shown with comparison to the parental, non-immortalized HFK
cell line. With Western blot analysis, we found that TRF2 was up-regulated in HPV16and hTERT- immortalized cells compared to their parental normal cells (Figure 4.2). No
notable difference in TIN2 and POT1 expression levels in transformed cells were
observed, whereas RAP1 was down-regulated in both immortalized cells to differing
extents and WRN was elevated in hTERT-immortalized cells.

Interaction of telomere-related proteins with predicted TRF binding sites in the
HPV16 genome
Telomere binding factors are comprised of six core proteins such as TRF1,
TRF2, POT1, RAP1, TIN2, and TPP1 (279). If TRF binding sites found in the late region
of HPV16 recruit shelterin and/or DNA repair factors to be utilized by the viral genome, it
is reasonable that these proteins bind to these sites by ChIP assay. For purposes of this
study, TRF2, Pot1, Tin2, and the telomere associated BLM helicase were examined for
binding to these sites using the ChIP Assay. The results showed that all of the factors
bound with varying affinity to the sequences of telomere nonamer sequences from
HPV16 (Fig 4.3). Non-specific rabbit antibody and ribosome L30 PCR primer set was
used for a negative control to demonstrate that no non-specific chromatin pull-down was
occurring.

Mutation of TRF Binding Sites in HPV Late Region Containing Plasmids
Further studies were performed to investigate what role TRF binding sites from
the late region of HPV16 played in stable plasmid replication and maintenance. As such,
site-directed mutagenesis was used to alter the nucleotide sequence of these binding
sites and replace them with an MluI restriction site to prevent protein binding and for
identification of successful mutagenesis. Plasmid pPA111 (mtc 2) contains nucleotide
4538-5072 of the L2 open reading frame, a yeast Autonomous Replicating Sequence
(ARS) but no centromere (CEN), and the HPV16 TRF binding site labeled as site A.
Upon introducing the mutation into pPA111 and transforming YPH500 yeast, a complete
loss of successful long-term replication of plasmid as determined by nutritional selection
on –Ura media was introduced (Figure 4.4A).

The pPA113 (mtc3) plasmid contains nucleotides 6151-6951 of the HPV16 L1
ORF. It contains the B and C TRF binding sites, and similarly has a yeast ARS
sequence but no CEN. EMSA analysis was used to confirm that knockout of the TRF
sites successfully abrogated gel shift with nuclear extract protein similar to site A (Figure
4.4B). Unlike pPA111, however, mutation of the TRF binding sites in the pPA113
plasmid did not result in complete loss of stable replication in yeast (Figure 4.4B).
Southern analysis of genomes isolated from yeast identified that the pPA113 mutant
plasmids were successfully replicating episomally with a slight shift in copy number
(Figure 4.4B).
Given the result from pPA111 and the stability results from pPA113, it was
desirable to explore whether the TRF binding site maintenance effect represents a
separate mechanism outside of or in addition to segregation. As such, the question was
posed to examine what effect could be observed with deletion of the TRF binding sites in
a plasmid that possesses neither ARS nor CEN sequences and is completely reliant on
HPV16 late-region signals for plasmid stability. Towards this end, plasmid pPA103-2, a
truncation mutant of HPV16 with the early genes removed by restriction digest with Spe1
to Brs361 (nucleotides 1462-4337), was used to observe what effect mutation of the
TRF binding sites would have on plasmid replication and maintenance in yeast.
Quikchange XL site-directed mutagenesis was performed to delete B, C, and BC from
pPA103-2 and YPH500 yeast were transfected with the resultant mutant plasmids.
pPA103-2ΔB transformed yeast replicate robustly and with similar growth and stability
characteristics to pPA103-2. However, removal of the C binding site resulted in a
plasmid which could support only limited yeast growth, presumably due to an observed
dramatic reduction in plasmid copy number as observed by Southern blot of the

extracted circular genomes (Figure 4.5A and 4.5B). The double mutant pPA103-2ΔBC
was incapable of replicating stably in yeast and was thus not analyzed by Southern.

Influence of TRF binding sites on HPV16 DNA maintenance in Human Cells
Several studies in EBV have proven that nonamers which resemble TRF binding
sequences contribute to the maintenance function of OriP containing plasmids (12, 88).
TRF proteins and associated partners can interact with the predicted TRF binding sites
in the HPV16 subgenomic region we had mapped for maintenance function (Figure 4.2).
To investigate the role of TRF binding sites in the HPV16 genome maintenance in
mammalian cells, the well-established EBV replication and maintenance system was
used. The minimal replicator for EBV episomal DNA maintenance has been identified in
OriP that contains two distinct cis-elements responsible for separate processes:
replication and partitioning. DS (dyad symmetry) confers EBNA1-dependent replication
whereas FR (Family of Repeats) mediates partitioning. For HPV, it was speculated that
the late region containing TRF binding sites is required for efficient long-term
maintenance. To directly test this, replication and partitioning elements were uncoupled
by constructing hybrid origins which contain the DS element of EBV OriP and various
TRF mutants in the background of pPur (Fig 4.6A). Plasmid containing hybrid origins
should replicate in an EBNA-1-dependent fashion and they have successfully been
utilized to verify cis-elements of other DNA tumor viruses (271, 272).
293E cells stably expressing EBNA1 were transfected with each hybrid origin
and either 2380.1 (intact EBV OriP) or 2380.2 (EBV OriP without FR) as controls. To
rule out the potential effects of neighboring sequence and plasmid size on DNA retention
and stability, a set of TRF mutants were created by either singly or multiply mutating

TRF binding sites in the plasmid 2380.5 (Fig 4.6A) similar to those created in yeast
plasmids. After transfection, cells were grown in the presence of puromycin to select for
plasmid containing cells. After 4 days under a selective condition, outgrowing colonies
were released from drug selection and grown in the absence of the drug for another 2
weeks. DNAs were Hirt extracted at the first and fourteen days after removal of the
drug. Hirt-extracted DNAs were then subjected to DpnI digestion and DpnI-resistant
species were detected by Southern blot with a radiolabeled probe specific for GFP
sequence (Fig.4.6B). All experiments were performed in triplicate.
All TRF mutants had influence on copy number, as an increased plasmid copy
number was observed at day 14 compared to the control which contains intact EBV OriP
(Fig 4.6B). However, the effect on the change in copy number by most TRF mutants
seems marginal compared to the wild-type DNA harboring intact TRF binding sites. The
greatest copy number increases were observed in plasmids with the A and B sites
mutated singly and the BC double mutant. A copy number change was observed in a
mutant lacking TRF binding sites B and C (about 10 times higher). In summary, these
results indicated that mutating two out of three of the TRF binding sites reduced plasmid
copy number.
HPV16 E2 Interacts with TRF2 and Other Shelterin Components
Whether or not E2 is expressed during maintenance replication, at some point
during the HPV16 lifecycle E2 will be expressed and potentially interact with E2. OriP
plasmids, which contain the EBV latent origin of replication, rely on an interaction
between EBNA1, a functional homologue of HPV E2, and TRF2 for DNA replication and
plasmid segregation. In order to investigate whether HPV16 E2 interacted with TRF2,
Far Western blot was used. Purified E2 protein from transformed DH5α bacteria was run
on a polyacrylamide gel and transferred to a nitrocellulose membrane prior to probing

with purified individual shelterin proteins (TRF1, TRF2, Pot1) fused with a GST tag. The
resulting protein-protein complexes were probed with an anti-GST antibody. As shown in
Figure (4.7A), E2 was specifically bound by all three shelterin complex proteins as well
as the positive control protein L2, but not the negative control GST alone.
To further explore this, HPV16 E2 protein fused to a 6xHistidine tag was bound
to Ni-NTA beads and used to perform a pull-down assay to determine if shelterin
complex proteins were capable of interacting with E2. Bacterial lysates were harvested
containing GST-tagged shelterin component proteins, cleared with Ni-NTA beads alone,
and then mixed with Ni-NTA beads bound with E2. After extensive washing to remove
any non-specific binding, bound protein-protein complexes were analyzed by Western
Blot to identify proteins capable of binding to HPV16E2. We observed that E2 was
capable of pulling down GST-TRF1, TRF2, Rap1, Pot1, and Tin2, as well as positive
control L2, but again was not bound by the negative control GST alone (Figure 4.7B).
These results indicate that E2 is capable of interacted with several members of the
shelterin complex.
To examine if the interaction occurred in mammalian cells, we transformed both
293 cells as well as NIH3T3 fibroblast cells with a Flag-tagged E2 vector. 3T3 cells were
used as a means of increasing total E2 levels, as it is one of few cell lines capable of
tolerating long-term overexpression of E2 and could thus be passaged under drug
selection after transfection. Additional 3T3 cells were co-transfected with either a GFP
vector to check for transfection efficiency or a TRF2 overexpression plasmid. After 2 (for
293 cells) or 4 days (NIH3T3) of protein expression, cells were collected and total
protein lysate was harvested. Lysates were precleared with anti-mouse and anti-goat
antibody bound to Dynabeads protein G prior to being mixed with beads bound to either
anti-Flag antibody to pull-down the E2 protein or anti-TRF2 to pull-down the endogenous

TRF2 or, in the appropriate treatments, the overexpressed TRF2 from 3T3 cells. The
pull-down results were then analyzed by Western blot and probed with the counterpart
antibody to determine whether TRF2 and E2 interact in vitro in mammalian cell extracts.
As shown in Figure 8C and D, this appears to be the case, as the proteins are pulled
down very specifically through both antibodies. The combination of all three proteinprotein interaction results allows us to conclude with certainty that E2 interacts with
TRF2 in vitro and seems to be capable of interacting with a number of other shelterin
components as well.
Finally, to determine whether this interaction occurs In vivo, we performed
immunofluorescent co-localization studies. Cells were transfected with expression vector
for our Flag tagged E2 protein, a combination of E2 and EE tagged E1, or the Flag
vector alone, fixed to glass coverslips with paraformaldehyde, and stained with anti-Flag
and anti-TRF2 antibody followed by fluorescent secondary antibody (Alexa 488 and
633.) The results are shown in Fig. 4.8E. E2 appeared to consistently co-localize with
TRF2. Previously, the McBride laboratory had shown that HPV16 E2 co-localizes to
chromosomes more efficiently when E1 is co-transfected into cells, and that the E1-E2
complex induces localized DNA damage at the interaction site(255), leading to activation
of ATM and, among numerous other factors, phosphorylation and re-localization of
TRF2. We thus wished to observe whether including E1 with the E2 vector would alter
localization of the E2-TRF2 complex, and so co-transfected these factors. As shown in
Fig. 8E, the interaction with E2 and TRF2 appears to be separate from the E1-E2
nuclear foci.

DISCUSSION
Through this study, TRF2 and its binding partners within the shelterin complex
have been demonstrated to promote long-term maintenance strategy of HPV16.
Replication of the viral genome within cells leads to an overall up-regulation of telomere
maintenance factors in mammalian cells, and some of these factors are in turn capable
of binding spontaneously to nine-base sequences of telomere DNA found in the late
region of HPV16. Through the use of site-directed mutagenesis, loss of these nine-base
repeats induces increased instability with regards to copy-number and overall replicative
success in both mammalian cells as well as our well established S. cerevisiae based
HPV replication model. E2 protein, which plays a critical role in plasmid maintenance for
the virus, interacts with TRF2 as well as other members of the shelterin complex, as
shown through both in vitro and in vivo assays. Taken together, these results indicate an
important role for TRF2 and its subsequent binding partners in the HPV16 life cycle.
Chromatin immunoprecipitation was used to investigate the interaction of TRF2
and its associated proteins with TRF binding sites in HPV16 DNA and investigate
whether TRF2 partners that are associated with TRF2 can bind to the TRF binding sites.
TRF2 and other telomere-related proteins such as POT1, TIN2, and BLM helicase are
able to bind to TRF binding sites. A similar result has been observed with OriP in EBV.
Several studies in EBV have demonstrated that TRF2 binds to the TRF binding sites at
DS in OriP and contributes to the replication and plasmid maintenance function of OriP.
It is likely, then, that the shelterin end-protection complex, responsible for T and D loop
formation and protection from the NHEJ system, rather than the TRF1 dependent
complex that binds along the length of the telomere, is responsible for any TRF2
dependent viral-maintenance effects.

Separate studies in high risk HPVs (types 31 and 16) have reported that high
risk E6 is necessary for episomal maintenance in primary keratinocytes. While genetic
analyses have suggested that p53 degradation activity of E6 is necessary for stable
maintenance of high-risk HPV genomes (241), it was not clear whether other activity of
E6 in telomerase stimulation would provide additional stability to high-risk HPV
genomes. Since elevation of telomerase expression has an impact on expression
profiles of shelterin complex proteins as well (TRF1, TRF2, POT1, TIN2, TPP1, RAP1
and RecQ helicases), it is attractive to speculate that E6 facilitates viral DNA
maintenance by altering expression of these key factors. It was therefore hypothesized
that alteration of telomeric associated protein levels would be observed in keratinocytes
that have been immortalized by HPV16 DNA. Various transformed/immortalized cells as
well as normal primary keratinocytes were also included for comparison. Compared to
normal keratinocytes, TRF1, TRF2, and hTERT were expressed at higher levels in most
transformed cells. In general, the levels of these proteins were altered in transformed
cells to varying extents. Interestingly, we observed elevated expression of TRF2 in all
cells that are either virally or spontaneously transformed.
The two regions of HPV16 that contain maintenance signals in yeast (pPA111
and pPA113) coincided with maintenance functions mapped in mammalian cells. If these
sites play a role in stable HPV replication and maintenance in either host cell type, then
disrupting the sequence of these sites should lead to a reduction in plasmid stability in
both models. As such, site-directed mutagenesis was employed to disrupt TRF2 binding.
The YPH500 strain of yeast was then transformed with the plasmids in order to test for
loss of stability in terms of forming colonies on –Ura plates, growth rate in liquid media,
and reduction of copy number. pPA111 lost the ability to replicate stably in yeast with the
removal of the TRF A site. This result is different than what would be expected from a

deficiency in segregation, as budding yeast have a closed mitosis with a mother-cell bias
and, as such, loss of proper plasmid segregation would result in retention of the plasmid
in the original cell, leading to high copy number and growth of a small number of large
colonies on the plate. This phenotype was not observed. The presence of an ARS signal
within the plasmid rules out a defect in initiation of replication as well. Given that the
average loss rate of plasmids with no maintenance signal in yeast is approximately 25%
per cell generation, it is more likely that some post-replication defect has been
introduced through loss of the A site, leading to loss of the plasmid and cessation of
yeast growth after only a few cell generations, explaining the lack of colony formation.
Mutation of the B and C binding sites in pPA113 did not result in the same
dramatic decrease in stability seen in pPA111. YPH500 transformed with the mutant
plasmids possessed similar growth characteristics to the unmutated plasmid on solid
media. All three mutants replicated episomally. There was an increase in the loss rate of
plasmids with the B site removed, but not with C. As such, it is difficult to conclude what
effect removal of these sites was having on overall plasmid stability. However, when the
same mutations are introduced into PA103-2, a plasmid containing only the late region
of HPV16 and no ARS or CEN sequences, the results become more pronounced.
Mutation of only the B site did not significantly alter plasmid growth or stability, but loss
of C resulted in a significant reduction in growth rate and copy number, and the double
mutant was completely unstable, much like pPA111ΔA. The loss of growth from the C
mutant resulted from a significant reduction in plasmid copy number, leading to
insufficient production of the Ura3 gene product to sustain yeast growth. This strongly
suggests that the successful growth of pPA113ΔC is due to the ARS+ vector backbone
which the plasmid is cloned into and, thus, that the C site may be playing a role in

successful completion of plasmid replication or prevention of integration into host
chromosomes, rather than segregation.
To expand these results to the effect of TRF binding sites on the long-term
maintenance of HPV DNA in mammalian cells, a heterologous replicon system that has
been developed to study the mechanism of stable replication and plasmid maintenance
was used (271, 272). The hybrid origin replicon contains the EBV DS that conveys
EBNA1 dependent replication while different viral cis elements can be replaced at the
partitioning part of the EBV OriP. This replicon allows for examination of the activity of
the viral cis maintenance elements based on the capability to substitute for function of
FR. Using EBV-DS/HPV16-maintenance element hybrid origins that contain various
truncated derivatives, we observed that the HPV cis maintenance element is able to
provide DNA stability and slightly increases plasmid copy number.
Mutation of the TRF binding sites to prevent TRF2 binding in these cells had
some effect on plasmid maintenance, but did not necessarily coincide with the results
observed in yeast. Notably, the PA103-2ΔBC plasmid which was unable to replicate in
yeast induces an increase in copy number in mammalian cells. None of the mammalian
cell plasmid mutants induced a reduction in copy number compared to the unmutated
plasmid. While the ΔA mutation in pPA111 induced a complete loss of plasmid viability in
yeast, it yielded only a moderate copy number increase in human cells. It is apparent,
then, that some differences exist in the phenotypes of these mutants between the two
systems.
While these results do not correlate exactly between the two models, the
significance of the results is that alteration of TRF binding sites leads to changes in
plasmid copy number. It is likely that, during evolutionary divergence, mammalian cells

have developed complementary DNA maintenance systems which are masking the
results observed in yeast. Variations in result between systems can likely be contributed
to the presence of multiple binding sites such as MARS, HMG, TopoII, and CENP-B
present in the maintenance element in the late region of HPV16 and, thus, a differential
ability to bind and utilize these sites between the two model systems as well as
differences in the telomere maintenance factor dependent phenotype between these two
organisms. It is also possible that the inclusion of OriP and EBNA1 may have reduced
the effect of mutating TRF2 sites in our model. The fact remains, however, that alteration
of these sites leads to a change in plasmid copy number and, by inference, an overall
reduction in plasmid stability.
TRF2 is also important in the life-cycle of other DNA viruses that possess longterm infection strategies comparable to papillomaviruses. Notably, EBV and KSHV
proteins EBNA1 and LANA have been shown to interact with TRF2, and evidence shows
that these interactions are important for the maintenance replication of plasmids
containing the EBV latent origin, OriP(85, 87, 149). HPV E2 proteins, while not
possessing sequence identity, possess similar functions to LANA and EBNA1 and
consist of the same unique protein fold as these viral factors. This work demonstrates
that HPV16 E2 protein interacts with TRF2 through in vitro and in vivo methods, as well
as a number of other factors from the telomere maintenance shelterin complex. Further
work is necessary to investigate the functional significance of this interaction, but it
suggests that HPV16 may be capable of utilizing TRF2 similarly to EBV.
Efficient maintenance is a result of the sum of a virus’s interactions with the
infected cells’ replication, repair, and segregation machineries, as they have been shown
to exhibit compensatory effects for viral genome retention (272). Evidence in BPV
showed that viral genomes are segregated nonrandomly into both daughter cells and the

average copy number of viral genomes per infected cell does not fluctuate widely (209).
It has been described in several latent DNA viruses such as EBV and KSHV that the
viruses adopt similar strategies to maintain their genomes in host cells. These
observations imply that a key requirement of papillomavirus stability is regulation of copy
number for stable, long-term DNA maintenance in infected cells. The copy number
fluctuations observed due to removal of TRF binding sites in this study may reflect a loss
of that regulation.
The specific role TRF2 plays in the long-term persistence of HPVs is unclear.
While it was initially hypothesized that these binding sites may be important for plasmid
segregation, some of our results may implicate an alternate maintenance mechanism.
Removal of the binding sites from plasmids with intact origins of replication in both
mammalian and yeast plasmid constructs did not result in plasmid behavior consistent
with a loss of segregation. The experiments with removal of the B and C binding sites
from PA113 in particular do not reflect a loss of plasmid segregation. Rather, the defects
could result in overall induction of plasmid instability and copy-number fluctuation
through an alternate maintenance mechanism. Recent results from the Lieberman
laboratory have indicated that, for EBV, one of TRF2’s primary functions is to recruit
DNA repair factors responsible for resolving Holiday Junctions to both improve postreplication processing of the viral plasmids as well as improve segregation
efficiency(92). Given the observed fluctuations in copy number after induction of TRF
binding site mutations, as well as the loss of replicative stability for pPA111ΔA, despite
the presence of an ARS sequence, it is possible that similar utilization of the DNA repair
systems may be at work here. A number of recent studies have similarly highlighted the
importance of the DNA repair systems for papillomaviral replicative success (125, 218,

255), Further work will need to be completed to investigate the possible role TRF2
proteins may play in recruiting and/or utilizing these factors.

Figure 4.1 Telomere Repeats Within the HPV16 Genome A) Predicted telomererelated factor binding sites (A-D) within the HPV16 genome were discovered. Three of
these sites (A-C) fall within L1 and L2 regions mapped for maintenance function. The
consensus TRF binding site is shown below the map. B) The distribution of predicted
TRF binding sites in selected HPV genomes is shown (red boxes). Statistical analysis
revealed that greater than 50% of the predicted binding sites were in the late region of
HPV genomes (L1 and L2 genes; indicated by blue shading). No identifiable TRF
binding sites were detected in the BPV1 genome. Table 1 lists PCR primers used for
mutation of TRF binding sites within subsequent plasmids from later in the work as well
as the expected PCR product sizes.
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Table 4.1 Primers used to amplify TRF binding consensus sequences.
TRF binding site

Primer sequences

(nucleotides)

A
(4849-4855)
B
(6198-6204)

sizes (bp)

5’ACCCATCTGTATTGCAGCCTC3’

5’ATGCAGCAAATGCAGGTGTG3’

(6778-6784)

5’TCTTCTAGTGTGCCTCCTGG3’

Neg

123

5’CACCTGGATTTACTGCAACATTGG3’
5’AGCACAGGGCCACAATAATG3’

(7863-7869)

192

5’AACTTGTTGTGTTGTGCGAC3’

C

D

PCR product

5’CTAAGGCCAACTAAATGTCACC3’

283

186

5’CGATTTCGGTTACGCCCTTAG3’
5’??3’
5’?3’

200

Figure 4.2 Western blot analysis for levels of telomere-related proteins in normal
keratinocytes, those harboring HPV16, or transformed with hTert. Whole cell
extracts were prepared from 4 day-old cells using SDS lysis buffer. Equal amount of
protein extract were subjected to SDS-PAGE electrophoresis and then hybridized with
specific antibody against protein of interest. Expression levels of telomere-related protein
(TRF2, TIN2, POT1, RAP1, and WRN) in transformed cell compared to parental normal
counterpart. HPV16-NHFK (HPV16 transformed neonatal human foreskin keratinocyte
cells), and hTERT-HFK (hTERT immortalized human foreskin keratinocyte cells).
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Figure 4.3 Analysis of telomere-related proteins binding to the TRF binding sites
in the viral genome by in vitro ChIP assay. ChIP was performed in vitro using
plasmid DNA with the HPV16 subgenomic fragment containing TRF binding sites
incubated with 293 nuclear extract and soluble nuclear pallet. The DNA-protein
complexes were then crosslinked and processed as described in the materials and
methods section. To determine proteins bound at TRF binding sites,
immunoprecipitations were performed using no antibody (No Ab), anti-TRF2, anti-POT1,
anti-TIN2, or anti-BLM. A portion of material prior to subjection to immunoprecipitation
was saved to serve as a control for the amount of DNA added to each
immunoprecipitate (Input). PCRs were conducted using primers specific for the TRF
binding site, indicated by A-D as in Fig 4.1 (primer sequences are shown in the Material
and Methods section).
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Figure 4.4 Mutation of TRF binding sites disrupt plasmid stability in yeast. (A). A
mutation in TRF binding site A was analyzed for binding to telomeric proteins in yeast
nuclear extract by gelshift (Left panel). Double stranded competitor TRF binding site was
used at 300X molar concentration to demonstrate specificity. The effect of TRF binding
site A disruption on episomal maintenance of an ARS+ plasmid (pPA111) in yeast is
shown in the (Right panel). TRF binding site A is essential for establishment of stable
episomes. Viable yeast containing the remaining mutant combinations were analyzed
by Southern analysis (B). Mutation of TRF binding site B consistently led to about a 50
percent increase in copy number, whereas the TRF binding site C mutation led to a
detectable decrease in copy number. A combination mutant in binding site B and C
revealed an intermediate phenotype. Triplicate quantification results are shown in the
right panel. EMSA comparing gel shift of WT vs. Mutated TRF B binding site is shown
below. A summary of TRF binding site mutant effects on yeast growth and plasmid copy
number is shown (C). Each mutation is indicated by an x below the affected binding site.
The arrows indicate the orientation of each of the TRF binding sites. The + and – signs
provide a qualitative summary of mutant effects.
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Figure 4.5 Mutation of the TRF binding sites B and C influence growth phenotypes
and plasmid copy number. A fragment of the HPV16 genome spanning nt 4334 to 56
was shown to replicate autonomously when linked to a Ura3 selectable marker (pPA1032) (A). Two predicted TRF binding sites (B and C) were mutated and each of the
resultant constructs (pPA103-2ΔB, pPA103-2ΔC, pPA103-2ΔBC), were analyzed for
viability and growth effects in yeast when plated on media lacking uracil. Viable
mutants were analyzed by Southern blot (B). While pPA103-2ΔB seemed to have a
slightly increased copy number, the ΔC mutant had a significantly reduced copy number.
ΔBC was incapable of sustaining long-term replication in yeast. DNA is run uncut and,
thus, bands for supercoiled will appear to have lower molecular weight while nicked
supercoiled will appear higher. Arrow indicates the expected supercoiled molecular
weight.
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Figure 4.6 Map of constructs containing mutated TRF binding site(s). The plasmid
2380.5 carries the HPV16 sequence (nt. 4466-7154) with three TRF binding sites, dyad
symmetry of EBV ori, and an EGFP gene. A series of mutant constructs, derived from
2380.5, contain single, double or triple mutations at TRF binding site as indicated in
diagram (A). These constructs were transfected into 293E cells and selected with
puromycin for 4 days. Each mutation is indicated by an x below the affected binding site.
The arrows indicate the orientation of each of the TRF binding sites. The + and – signs
provide a qualitative summary of mutant effects on copy number. (B) After release from
the drug, the transfected cells were grown under non-selective condition for another 14
days Hirt extraction was performed to collect low molecular weight DNA 14 days (day
14) after cells were released from the drug. Hirt-DNAs were then DpnI digested and
subjected to Southern analysis using EGFP gene as a probe. Experiments were
performed in triplicate. The band intensity was determined by densitometry. The
plasmid stability was shown as relative change in copy number. A summary of TRF
binding site mutant effects on copy number of 2380.5 plasmids containing the HPV16
late region sequences
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Figure 4.7 E2 interacts with TRF2 and other shelterin components. A) Purified Histagged E2 or negative bacterial extract was separated on an SDS PAGE gel and
transferred to nitrocellulose. Each blot was then probed with either GST-TRF1, GSTTRF2, GST-Pot1 or GST-HPV16L2 as a positive control. GST alone was used as a
negative control. Each blot was reacted with primary monoclonal antibody to GST and
secondary polyclonal antibody to mouse IgG, followed by development with ECL. An
interaction with the purified E2 protein is shown for TRF1, TRF2, Pot1 and for the
positive control HPV16 L2. GST alone shows no interaction with E2. B) His-tagged E2
protein was bound to Ni-NTA beads and used for pull-down in lysate containing either
GST tagged TRF1, TRF2, Pot1, Rap1, Tin2, HPV16 L2, or GST alone. Resulting protein
eluates were analyzed by western blot and probed for either GST (top) or His (bottom).

Negative

E2

Negative

E2

Negative

E2

Negative

E2

Negative

E2

Fig 4.7A

132

78
45.7
32.5

FW: GST-TRF1

GST-TRF2

GST-POT1

GST-HPV16L2

GST

α His
His-E2 Pulldown

GST-Tin2

GST-Pot1

GST-Rap1

GST-TRF2

GST-TRF1

GST-L2

GST

Fig 4.7B

α GST

E2

Figure 4.8 E2 TRF2 Interaction in Mammalian Cells A) Western blot showing crude
expression of Flag-E2 from expression vectors from 2 transfections in NIH3T3 cells.
Reblotting of the same membrane to demonstrate TRF2 levels is shown in B) C) Coimmunoprecipitation of E2-Flag by pull-down of TRF2. NIH3T3 cell lysate from 4 days
post-transfection with either E2-Flag or empty vector were mixed with Dynabeads
Protein G coupled to TRF2 antibody. Beads were collected, washed, and eluted directly
into Laemmli buffer and analyzed by western blot. D) 293 cells were transfected with the
same plasmid constructs as C). Lysates were collected and pull-down was performed
with Dynabeads bound with anti-Flag antibody. Western blot shown is probed with antiTRF2. E) 293 cells were transfected with Flag, E2-Flag, or E2 Flag with E1 plasmids
plasmid and fixed to glass coverslips prior to treatment with primary and fluorescent
secondary antibodies and visualization by confocal microscopy. Flag antibody is
visualized in red and endogenous TRF2 is shown in green. E2 co-localizes in diffuse
nuclear structures with TRF2 associated with DNA.
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Chapter 5
General Conclusions

Several tumor viruses interact with elements of the DNA Repair and Telomere
Maintenance systems [reviewed in (89, 201). The DNA repair systems are co-opted by a
number of other DNA viruses that utilize a long-term persistence strategy for survival
inside the nucleus. Additionally, Epstein Barr-Virus and Kaposi’s Sarcoma Herpesvirus
utilize factors from the telomere maintenance system for their own persistence: for
example, the TRF2 protein as a means of attracting elements of the homologous
recombination repair system to improve segregation and recruitment of the Origin
Recognition Complex (ORC) (85, 87). HPVs are also implicated in co-opting elements of
the DNA repair system as a means of initiating replication. This is done through the E1
protein triggering double-strand breaks, leading to recruit of ATM and a number of
downstream factors which, ultimately, are required for efficient replication.
The objective of this work was to identify cellular factors that HPVs utilize for their
DNA replication and maintenance of the genome. During the maintenance phase, the
virus expresses only low levels of its own replication proteins and DNA replicates once
per cell cycle. This mechanism of viral DNA replication is in contrast to the rolling-circle
mechanism observed during the vegetative phase, when high levels of viral DNA
replication proteins are expressed. It is likely, then, that the virus utilizes certain cellular
proteins that are necessary for cellular replication.
At some point during the viral lifecycle, E2 begins to be expressed and initiates
its functions in DNA replication and maintenance. E2 binds with high affinity to a DNA
site with sequence matching ATTg-N4-cAAT, with a high degree of sequence variability
in the four nucleotide internal spacer. While it was previously surmised that no specific
sequences were required in this spacer, my results have indicated that the specificity

varies by papillomavirus genus. The Deltapapillomaviruses, which include the BPV1
virus that was used for much of the early Papillomavirus E2 research, seem to be
essentially insensitive, having a GC percentage of around 50%. Alphapapillomaviruses,
by contrast, were observed to have a significantly lower GC content, which agrees with
previous research demonstrating that HPV16 requires AT nucleotides in their spacer to
maintain proper binding affinity. This is theorized to be due to BPV E2’s greater ability to
distort the DNA helix’s shape to accommodate the E2 binding pocket compared to
HPV16’s, a trend that appears to remain consistent throughout their respective genera.
The other papillomavirus genera seemed to all fall into the middle of these two extremes,
containing an average GC content of approximately 30%. Interestingly, these trends
further correlate with adaptive radiation to infect different cell types. The majority of PV’s
infect cutaneous keratinocytes. The Alpha genus contains members which are capable
of infecting both cutaneous and mucosal keratinocytes, and the Delta genus contains
members which are capable of infecting fibroblasts.
While newly discovered papillomaviruses are classified based on sequences
from the L1 Orf, phylogenetic analysis based on different HPV open reading frames
allows investigators to group Papillomaviral species by varying characteristics of that
gene. As such, we performed phylogenetic analysis of the E2 ORF of all
papillomaviruses, demonstrating that, while all the viruses sorted into their clades based
on their respective genera, some differences were apparent from L1 phylogenetic trees.
The genus which showed the most evolutionary distance from the others was the
Deltapapillomavirus genus. This correlates with previous results indicating the greater
numbers of E2BSs in Deltapapillomaviral genomes and their greater ability to deform
DNA structure with their E2 protein as compared to the other Papillomaviral genera
(177). Additionally, the Alpha PVs can be divided into two sub-clades within their genus,

one of which contained all of the Alphapapillomaviruses which are classified as “high
risk” for progression to cervical cancer. The second group contained the majority of the
Alphapapillomaviruses which were still capable of infecting cutaneous keratinocytes. As
expected, the first group also showed a much higher reliance on low GC content of their
binding sites compared to the second. This coupled with the E2BS spacer data makes it
tempting to associate the sites of infection with reliance of E2 on GC content of spacers,
particularly given that the differential binding affinity of the E2 binding sites affects the
order in which they are occupied and, thus, the levels of gene expression during the
infection. These differences could theoretically allow for precision regulation of gene
expression and plasmid replication.
The yeast system allows for simplification and dissection of replication and
maintenance functions for PVs. It has previously been demonstrated that HPVs are
capable of replicating in yeast in the absence of any HPV specific genes. It is likely,
then, that the host factors which play a key role in replication in mammalian cells are
similarly involved in replication in yeast. Surprisingly, we discovered that a subset of
HPVs are capable of replicating in this system. HPVs 16, 31, and 6 all replicate robustly,
while 11, 18, and BPV1 do not. This failure to initiate stable replication does not match
up with any specific phylogenetic groupings, including those performed in this report, but
it does correlate with an observed lack of nine-base telomeric repeat sites in the late
regions of the non-replicators. BPV1, in particular, comes from the very divergent
Deltapapillomavirus genera and relies on Brd4 for segregation, unlike other HPVs that
only utilize Brd4 for transcription. Working from the hypothesis that these binding sites
were involved in yeast replication, we designed plasmid constructs whereby we could
remove these nine-base repeats by site-directed mutagenesis. The results showed that,
while the results for removing particular sites did not correlate with a loss of segregation

effect, mutation of TRF binding sites had an overall disruptive effect on plasmid stability,
particularly when multiple mutations were introduced into the same plasmid. This
instability was reflected by changes in DNA copy number.
The role of TRF2 in EBV replication involves an interaction between TRF2 and
the EBV EBNA1 protein, which is a structural and functional homologue of the HPV E2
protein. To investigate if a similar interaction could be observed with E2, Far Western
blots, bacterial GST-His pull-downs, and co-immunoprecipitation of mammalian proteins
were performed. These studies demonstrated that E2 and TRF2 interact. Additionally,
E2 interacted with other telomere maintenance and DNA repair proteins, namely TRF1,
Pot1, Rap1, and Tin2. This agreed with results from CHIP assay demonstrating that
similar DNA repair/telomere maintenance proteins interact with HPV16 telomere repeat
sequences and that some of these factors are upregulated in cells after immortalization
with HPV16 or hTert. Additionally, E2 co-localizes with TRF2 in the nucleus of cells
independent of the E1-E2 complexes that were observed. Collectively, this evidence
suggests that TRF2/E2 interactions are similar to EBNA1/TRF2 complex, where the
purpose facilitates binding of repair factors to the DNA binding site in order to improve
plasmid stability and segregation fidelity after DNA replication. Given the growing
evidence that HPV16 DNA replication is initiated through E1 protein inducing sitespecific double strand breaks in host chromosomes and, in doing so, initiates an
activation of the host DNA repair response, which is necessary for Papillomavirus
replication. Thus, one of TRF2’s important functions may be to prevent integration of the
newly replicated HPV16 DNA into the host chromosome during the repair response, a
function that is crucial for stability of the viral chromosome. Another possibility is that the
proteins that facilitate post-replication processing of replication products are required for

disentangling plasmids after once-per-cell-cycle replication and processing concatamers
after rolling circle replication.
Our proposed model for HPV utilization of TRF2 is similar to that which has been
proposed for EBV and KSHV. One of TRF2’s important functions in cells is to loop the
end of the chromosome back into a D-loop structure which protects the telomere ends
from attack by the Non-Homologous End Joining System. In EBV and KSHV, the
proteins similarly bind latent viral origins and reshape the viral chromosomes into a
higher order chromatin structure. This would increase the frequency of initiation of DNA
replication at these sites as well as down-stream maintenance of the DNA replication
products. The interaction between TRF2 proteins with EBNA1 or LANA is critical for this
process, particularly in KSHV, which does not contain TRF binding sites within the
terminal repeat. We propose that HPV16 utilizes a similar loop-remodeling activity to
improve its own long-term plasmid stability, as evidenced by the interaction of E2 with
shelterin proteins and the subsequent plasmid instability if TRF binding sites are
mutated. Further work will be required to elucidate the precise mechanisms of these
processes.
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